ORGANIC LIGHT-EMITTING DEVICE

CROSS-REFERENCE TO RELATED APPLICATION

This application claims priority to Korean Patent Application No. 10-2018-0071035, filed on Jun. 20, 2018, in the Korean Intellectual Property Office, and all the benefits accruing therefrom under 35 U.S.C. § 119, the content of which is incorporated herein in its entirety by reference.

BACKGROUND
1. Field

One or more embodiments relate an organic light-emitting device including an emission layer, the emission layer including a host, a dopant, and a sensitizer.

2. Description of the Related Art

Organic light-emitting devices (OLEDs) are self-emission devices that produce full-color images, and that also have wide viewing angles, high contrast ratios, short response times, and excellent characteristics in terms of brightness, driving voltage, and response speed, compared to the devices in the art.

In an example, an organic light-emitting device includes an anode, a cathode, and an organic layer disposed between the anode and the cathode, wherein the organic layer includes an emission layer. A hole transport region may be disposed between the anode and the emission layer, and an electron transport region may be disposed between the emission layer and the cathode. Holes provided from the anode may move toward the emission layer through the hole transport region, and electrons provided from the cathode may move toward the emission layer through the electron transport region. The holes and the electrons recombine in the emission layer to produce excitons. These excitons transit from an excited state to a ground state, thereby generating light.

Various types of organic light emitting devices are known. However, there still remains a need in OLEDs having low driving voltage, high efficiency, high brightness, and long lifespan.

SUMMARY

Aspects of the present disclosure provide an organic light-emitting device including an emission layer, the emission layer including a host, a dopant, and a sensitizer.

Additional aspects will be set forth in part in the description which follows and, in part, will be apparent from the description, or may be learned by practice of the presented embodiments.

An aspect provides an organic light-emitting device including:

a first electrode;

a second electrode; and

an organic layer disposed between the first electrode and the second electrode,

wherein

the organic layer includes an emission layer,

the emission layer includes a host, a dopant, and a sensitizer,

the host does not include a metal atom,

the dopant emits light, and the light has a decay time of about 100 nanoseconds or less, and

the sensitizer includes an organometallic compound represented by one selected from Formulae 1 and 2:

embedded image

In Formulae 1 and 2,

M₁₁and M₁₂may each independently be selected from beryllium (Be), magnesium (Mg), aluminum (Al), calcium (Ca), titanium (Ti), manganese (Mn), cobalt (Co), copper (Cu), zinc (Zn), gallium (Ga), germanium (Ge), zirconium (Zr), ruthenium (Ru), rhodium (Rh), palladium (Pd), silver (Ag), rhenium (Re), platinum (Pt), gold (Au), iridium (Ir), osmium (Os), hafnium (Hf), europium (Eu), terbium (Tb), and thulium (Tm),

A₁₁to A₁₄and A₂₁to A₂₄may each independently be selected from a C₅-C₆₀carbocyclic group and a C₁-C₆₀heterocyclic group,

Y₁₁to Y₁₄and Y₂₁to Y₂₄may each independently be selected from N and C,

T₁₁to T₁₄may each independently be selected from a covalent bond, a coordinate bond, O, S, N(R₁₅), P(R₁₅), B(R₁₅), C(R₁₅)(R₁₆), and Si(R₁₅)(R₁₆),

T₂₁to T₂₄may each independently be selected from a covalent bond, a coordinate bond, O, S, N(R₂₅), P(R₂₅), B(R₂₅), C(R₂₅)(R₂₆), and Si(R₂₅)(R₂₆),

L₁₁to L₁₃may each independently be selected from *—O—*′, *—S—*′, *—C(R₁₇)(R₁₈)—*′, *—C(R₁₇)═*′, *═C(R₁₇)—*′, *—C(R₁₇)═C(R₁₈)—*′, *—C(═O)—*′, *—C(═S)—*′, *—C≡C—*′, *—B(R₁₇)—*′, *—N(R₁₇)—*′, *—P(R₁₇)—*′, *—Si(R₁₇)(R₁₈)—*′, *—P(R₁₇)(R₁₈)—*′, and *—Ge(R₁₇)(R₁₈)—*′,

L₂₁to L₂₄may each independently be selected from *—O—*′, *—S—*′, *—C(R₂₇)(R₂₈)—*′, *—C(R₂₇)═*′, *═C(R₂₇)—*′, *—C(R₂₇)═C(R₂₈)—*′, *—C(═O)—*′, *—C(═S)—*′, *—C≡C—*′, *—B(R₂₇)—*, *—N(R₂₇)—*′, *—P(R₂₇)—*′, *—Si(R₂₇)(R₂₈)—*′, *—P(R₂₇)(R₂₈)—*′, and *—Ge(R₂₇)(R₂₈)—*′,

a11 to a13 and a21 to a24 may each independently be selected from 0 and 1,

the sum of a11 to a13 may be selected from 1, 2, and 3, and the sum of a21 to a24 may be selected from 1, 2, 3, and 4,

when a11 is 0, (L₁₁)_a11may be a covalent bond, when a12 is 0, (L₁₂)_a12may be a covalent bond, when a13 is 0, (L₁₃)_a13may be a covalent bond, when a21 is 0, (L₂₁)_a21may be a covalent bond, when a22 is 0, (L₂₂)_a22may be a covalent bond, when a23 is 0, (L₂₃)_a23may be a covalent bond, and when a24 is 0, (L₂₄)_a24may be a covalent bond,

L₁₅to L₁₈and L₂₅to L₂₈may each independently be selected from a substituted or unsubstituted C₅-C₃₀carbocyclic group and a substituted or unsubstituted C₁-C₃₀heterocyclic group,

a15 to a18 and a25 to a28 may each independently be selected from 0, 1, 2, 3, 4, and 5,

R₁₁to R₁₈and R₂₁to R₂₈may each independently be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, —SF₅, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C₁-C₆₀alkyl group, a substituted or unsubstituted C₂-C₆₀alkenyl group, a substituted or unsubstituted C₂-C₆₀alkynyl group, a substituted or unsubstituted C₁-C₆₀alkoxy group, a substituted or unsubstituted C₃-C₁₀cycloalkyl group, a substituted or unsubstituted C₁-C₁₀heterocycloalkyl group, a substituted or unsubstituted C₃-C₁₀cycloalkenyl group, a substituted or unsubstituted C₁-C₁₀heterocycloalkenyl group, a substituted or unsubstituted C₆-C₆₀aryl group, a substituted or unsubstituted C₇-C₆₀alkylaryl group, a substituted or unsubstituted C₆-C₆₀aryloxy group, a substituted or unsubstituted C₆-C₆₀arylthio group, a substituted or unsubstituted C₁-C₆₀heteroaryl group, a substituted or unsubstituted C₂-C₆₀alkylheteroaryl group, a substituted or unsubstituted C₁-C₆₀heteroaryloxy group, a substituted or unsubstituted C₁-C₆₀heteroarylthio group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q₁)(Q₂)(Q₃), —B(Q₁)(Q₂), —N(Q₁)(Q₂), —P(Q₁)(Q₂), —C(═O)(Q₁), —S(═O)(Q₁), —S(═O)₂(Q₁), —P(═O)(Q₁)(Q₂), and —P(═S)(Q₁)(Q₂),

R₁₇and R₁₁, R₁₇and R₁₂, R₁₇and R₁₃, and/or R₁₇and R₁₄may optionally be linked to form a substituted or unsubstituted C₅-C₆₀carbocyclic group or a substituted or unsubstituted C₁-C₆₀heterocyclic group,

R₂₇and R₂₁, R₂₇and R₂₂, R₂₇and R₂₃, and/or R₂₇and R₂₄may optionally be linked to form a substituted or unsubstituted C₅-C₆₀carbocyclic group or a substituted or unsubstituted C₁-C₆₀heterocyclic group,

R₁₁and R₁₂, R₁₂and R₁₃, R₁₃and R₁₄, and/or R₁₁and R₁₄may optionally be linked to form a substituted or unsubstituted C₅-C₆₀carbocyclic group or a substituted or unsubstituted C₁-C₆₀heterocyclic group,

R₂₁and R₂₂, R₂₂and R₂₃, R₂₃and R₂₄, and/or R₂₁and R₂₄may optionally be linked to form a substituted or unsubstituted C₅-C₆₀carbocyclic group or a substituted or unsubstituted C₁-C₆₀heterocyclic group,

R₁₇and R₁₈may optionally be linked to form a substituted or unsubstituted C₅-C₆₀carbocyclic group or a substituted or unsubstituted C₁-C₆₀heterocyclic group, and R₂₇and R₂₈may optionally be linked to form a substituted or unsubstituted C₅-C₆₀carbocyclic group or a substituted or unsubstituted C₁-C₆₀heterocyclic group,

b11 to b14 and b21 to b24 may each independently be selected from 1, 2, 3, 4, and 5,

n11 to n14 and n21 to n24 may each independently be selected from 1, 2, 3, 4, 5, 6, 7, and 8,

Q₁to Q₃may each independently be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, a C₁-C₆₀alkoxy group, a C₃-C₁₀cycloalkyl group, a C₁-C₁₀heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₁-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₆-C₆₀aryloxy group, a C₆-C₆₀arylthio group, a C₁-C₆₀heteroaryl group, a C₂-C₆₀alkylheteroaryl group, a C₁-C₆₀heteroaryloxy group, a C₁-C₆₀heteroarylthio group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a C₁-C₆₀alkyl group substituted with at least one selected from deuterium, —F, a cyano group, a C₁-C₆₀alkyl group, and a C₆-C₆₀aryl group, and a C₆-C₆₀aryl group substituted with at least one selected from deuterium, —F, a cyano group, a C₁-C₆₀alkyl group, and a C₆-C₆₀aryl group, and

* and *′ each indicate a binding site to a neighboring atom.

Another aspect provides an organic light-emitting device including:

a first electrode;

a second electrode;

a plurality of light-emitting units in the number of m disposed between the first electrode and the second electrode and including at least one emission layer; and

a plurality of charge generation layers in the number of m−1 disposed between two neighboring light-emitting units among the light-emitting units in the number of m and including an n-type charge generation layer and a p-type charge generation layer,

wherein m is an integer of 2 or more,

a maximum emission wavelength of light emitted by at least one light-emitting unit among the light-emitting units in the number of m is different from a maximum emission wavelength of light emitted by at least one light-emitting unit among the other light-emitting units,

the emission layer includes a host, a dopant, and a sensitizer,

the host does not include a metal atom,

the dopant emits light, and the light has a decay time of about 100 nanoseconds or less, and

the sensitizer includes an organometallic compound represented by one selected from Formulae 1 and 2.

Another aspect provides an organic light-emitting device including:

a first electrode;

a second electrode; and

a plurality of emission layers in the number of m disposed between the first electrode and the second electrode,

wherein m is an integer of 2 or more,

a maximum emission wavelength of light emitted by at least one emission layer among the emission layers in the number of m is different from a maximum emission wavelength of light emitted by at least one emission layer among the other emission layers,

the emission layer includes a host, a dopant, and a sensitizer,

the host does not include a metal atom,

the dopant emits light, and the light has a decay time of about 100 nanoseconds or less, and

the sensitizer includes an organometallic compound represented by one selected from Formulae 1 and 2.

BRIEF DESCRIPTION OF THE DRAWINGS

These and/or other aspects will become apparent and more readily appreciated from the following description of the embodiments, taken in conjunction with the accompanying drawings in which:

FIG. 1 is a schematic view of an organic light-emitting device 10 according to an embodiment;

FIG. 2 is a schematic diagram showing energy transfer within an emission layer of an organic light-emitting device according to an embodiment;

FIG. 3 is a schematic view of an organic light-emitting device 100 according to another embodiment;

FIG. 4 is a schematic view of an organic light-emitting device 200 according to another embodiment;

FIG. 5 is a graph of external quantum efficiency (percent, %) versus brightness (candelas per square meter, cd/m²), which is a current density-external quantum efficiency graph of organic light-emitting devices manufactured according to Example 1 and Comparative Example 1; and

FIG. 6 is a graph of brightness (percent, %) versus time (hours, hr), which is a time-brightness graph of organic light-emitting devices manufactured according to Example 1 and Comparative Example 1.

DETAILED DESCRIPTION

Reference will now be made in detail to embodiments, examples of which are illustrated in the accompanying drawings, wherein like reference numerals refer to like elements throughout. In this regard, the present embodiments may have different forms and should not be construed as being limited to the descriptions set forth herein. Accordingly, the embodiments are merely described below, by referring to the figures, to explain aspects of the present description. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items. Expressions such as “at least one of,” when preceding a list of elements, modify the entire list of elements and do not modify the individual elements of the list.

It will be understood that when an element is referred to as being “on” another element, it can be directly in contact with the other element or intervening elements may be present therebetween. In contrast, when an element is referred to as being “directly on” another element, there are no intervening elements present.

It will be understood that, although the terms first, second, third etc. may be used herein to describe various elements, components, regions, layers, and/or sections, these elements, components, regions, layers, and/or sections should not be limited by these terms. These terms are only used to distinguish one element, component, region, layer, or section from another element, component, region, layer, or section. Thus, a first element, component, region, layer, or section discussed below could be termed a second element, component, region, layer, or section without departing from the teachings of the present embodiments.

The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting. As used herein, the singular forms “a,” “an,” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise.

The term “or” means “and/or.” It will be further understood that the terms “comprises” and/or “comprising,” or “includes” and/or “including” when used in this specification, specify the presence of stated features, regions, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, regions, integers, steps, operations, elements, components, and/or groups thereof.

Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this general inventive concept belongs. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and the present disclosure, and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.

Exemplary embodiments are described herein with reference to cross section illustrations that are schematic illustrations of idealized embodiments. As such, variations from the shapes of the illustrations as a result, for example, of manufacturing techniques and/or tolerances, are to be expected. Thus, embodiments described herein should not be construed as limited to the particular shapes of regions as illustrated herein but are to include deviations in shapes that result, for example, from manufacturing. For example, a region illustrated or described as flat may, typically, have rough and/or nonlinear features. Moreover, sharp angles that are illustrated may be rounded. Thus, the regions illustrated in the figures are schematic in nature and their shapes are not intended to illustrate the precise shape of a region and are not intended to limit the scope of the present claims.

“About” or “approximately” as used herein is inclusive of the stated value and means within an acceptable range of deviation for the particular value as determined by one of ordinary skill in the art, considering the measurement in question and the error associated with measurement of the particular quantity (i.e., the limitations of the measurement system). For example, “about” can mean within one or more standard deviations, or within ±30%, 20%, 10%, 5% of the stated value.

Description of FIGS. 1 and 2

In an embodiment, an organic light-emitting device is provided. FIG. 1 is a schematic view of an organic light-emitting device 10 according to an embodiment. Hereinafter, the structure of an organic light-emitting device according to an embodiment and a method of manufacturing an organic light-emitting device according to an embodiment will be described in connection with FIG. 1.

The organic light-emitting device 10 includes a first electrode 11, an organic layer 15, and a second electrode 19, which are sequentially stacked.

A substrate may be additionally disposed under the first electrode 11 or above the second electrode 19. For use as the substrate, any substrate that is used in general organic light-emitting devices may be used, and the substrate may be a glass substrate or a transparent plastic substrate, each having excellent mechanical strength, thermal stability, transparency, surface smoothness, ease of handling, and water resistance.

In one or more embodiments, the first electrode 11 may be formed by depositing or sputtering a material for forming the first electrode 11 on the substrate. The first electrode 11 may be an anode. The material for forming the first electrode 11 may be selected from materials with a high work function to facilitate hole injection. The first electrode 11 may be a reflective electrode, a semi-transmissive electrode, or a transmissive electrode. The material for forming the first electrode 11 may be indium tin oxide (ITO), indium zinc oxide (IZO), tin oxide (SnO₂), or zinc oxide (ZnO). In one or more embodiments, the material for forming the first electrode 11 may be metal, such as magnesium (Mg), aluminum (Al), aluminum-lithium (Al—Li), calcium (Ca), magnesium-indium (Mg—In), or magnesium-silver (Mg—Ag).

The first electrode 11 may have a single-layered structure or a multi-layered structure including two or more layers. For example, the first electrode 11 may have a three-layered structure of ITO/Ag/ITO, but the structure of the first electrode 110 is not limited thereto.

The organic layer 15 is disposed on the first electrode 11.

The organic layer 15 may include a hole transport region, an emission layer, and an electron transport region.

The hole transport region may be disposed between the first electrode 11 and the emission layer.

The hole transport region may include a hole injection layer, a hole transport layer, an electron blocking layer, a buffer layer, or any combination thereof.

The hole transport region may include only either a hole injection layer or a hole transport layer. In one or more embodiments, the hole transport region may have a hole injection layer/hole transport layer structure or a hole injection layer/hole transport layer/electron blocking layer structure, which are sequentially stacked in this stated order from the first electrode 11.

When the hole transport region includes a hole injection layer (HIL), the hole injection layer may be formed on the first electrode 11 by using one or more suitable methods, for example, vacuum deposition, spin coating, casting, and/or Langmuir-Blodgett (LB) deposition.

When a hole injection layer is formed by vacuum deposition, the deposition conditions may vary according to a material that is used to form the hole injection layer, and the structure and thermal characteristics of the hole injection layer. For example, the deposition conditions may include a deposition temperature of about 100° C. to about 500° C., a vacuum pressure of about 10⁻⁸torr to about 10⁻³torr, and a deposition rate of about 0 Angstroms per second (Å/sec) to about 100 Å/sec. However, the deposition conditions are not limited thereto, but embodiments of the present disclosure are not limited thereto.

When the hole injection layer is formed using spin coating, the coating conditions may vary according to the compound that is used to form the hole injection layer, and the desired structure and thermal properties of the hole injection layer to be formed. For example, the coating rate may be in the range of about 2,000 revolutions per minute (rpm) to about 5,000 rpm, and a temperature at which heat treatment is performed to remove a solvent after coating may be in the range of about 80° C. to about 200° C. However, the coating conditions are not limited thereto.

Conditions for forming a hole transport layer and an electron blocking layer may be understood by referring to conditions for forming the hole injection layer.

The hole transport region may include at least one selected from m-MTDATA, TDATA, 2-TNATA, NPB, p-NPB, TPD, Spiro-TPD, Spiro-NPB, methylated-NPB, TAPC, HMTPD, 4,4′,4″-tris(N-carbazolyl)triphenylamine (TCTA), polyaniline/dodecylbenzene sulfonic acid (PANI/DBSA), poly(3,4-ethylenedioxythiophene)/poly(4-styrene sulfonate) (PEDOT/PSS), polyaniline/camphor sulfonic acid (PANI/CSA), polyaniline/poly(4-styrene sulfonate) (PANI/PSS), a compound represented by Formula 201 below, and a compound represented by Formula 202 below:

embedded image

Ar₁₀₁and Ar₁₀₂in Formula 201 may each independently be selected from:

a phenylene group, a pentalenylene group, an indenylene group, a naphthylene group, an azulenylene group, a heptalenylene group, an acenaphthylene group, a fluorenylene group, a phenalenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylenylene group, a naphthacenylene group, a picenylene group, a perylenylene group, and a pentacenylene group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, a C₁-C₆₀alkoxy group, a C₃-C₁₀cycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₁-C₁₀heterocycloalkyl group, a C₁-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₆-C₆₀aryloxy group, a C₆-C₆₀arylthio group, a C₁-C₆₀heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group, and

xa and xb in Formula 201 may each independently be an integer from 0 to 5, or 0, 1 or 2.

For example, xa may be 1 and xb may be 0, but xa and xb are not limited thereto.

R₁₀₁to R₁₀₈, R₁₁₁to R₁₁₉, and R₁₂₁to R₁₂₄in Formulae 201 and 202 may each independently be selected from:

hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₁₀alkyl group (for example, a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, a hexyl group, and so on), or a C₁-C₁₀alkoxy group (for example, a methoxy group, an ethoxy group, a propoxy group, a butoxy group, a pentoxy group, and so on);

a C₁-C₁₀alkyl group and a C₁-C₁₀alkoxy group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof and a phosphoric acid group or a salt thereof;

a phenyl group, a naphthyl group, an anthracenyl group, a fluorenyl group, or a pyrenyl group; or

a phenyl group, a naphthyl group, an anthracenyl group, a fluorenyl group, and a pyrenyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₁₀alkyl group, and a C₁-C₁₀alkoxy group,

but embodiments of the present disclosure are not limited thereto.

R₁₀₉in Formula 201 may be selected from:

a phenyl group, a naphthyl group, an anthracenyl group, and a pyridinyl group; and

a phenyl group, a naphthyl group, an anthracenyl group, and a pyridinyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a naphthyl group, an anthracenyl group, and a pyridinyl group.

According to an embodiment, the compound represented by Formula 201 may be represented by Formula 201A below, but embodiments of the present disclosure are not limited thereto:

embedded image

R₁₀₁, R₁₁₁, R₁₁₂, and R₁₀₉in Formula 201A may be understood by referring to the description provided herein.

For example, the compound represented by Formula 201, and the compound represented by Formula 202 may include compounds HT1 to HT20 illustrated below, but are not limited thereto.

embedded image

A thickness of the hole transport region may be in a range of about 100 Å to about 10,000 Å, for example, about 100 Å to about 1,000 Å. When the hole transport region include at least one selected from a hole injection layer and a hole transport layer, a thickness of the hole injection layer may be in a range of about 100 Å to about 10,000 Å, for example, about 100 Å to about 1,000 Å, and a thickness of the hole transport layer may be in a range of about 50 Å to about 2,000 Å, for example, about 100 Å to about 1,500 Å. While not wishing to be bound by theory, it is understood that when the thicknesses of the hole transport region, the hole injection layer, and the hole transport layer are within these ranges, satisfactory hole transporting characteristics may be obtained without a substantial increase in driving voltage.

The hole transport region may further include, in addition to these materials, a charge-generation material for the improvement of conductive properties. The charge-generation material may be homogeneously or non-homogeneously dispersed in the hole transport region.

The charge-generation material may be, for example, a p-dopant. The p-dopant may be one selected from a quinone derivative, a metal oxide, and a cyano group-containing compound, but embodiments of the present disclosure are not limited thereto. Non-limiting examples of the p-dopant are a quinone derivative, such as tetracyanoquinonedimethane (TCNQ) or 2,3,5,6-tetrafluoro-tetracyano-1,4-benzoquinonedimethane (F4-TCNQ); a metal oxide, such as a tungsten oxide or a molybdenium oxide; and a cyano group-containing compound, such as Compound HT-D1, HP-1, or F6TCNNQ, but are not limited thereto.

embedded image

The hole transport region may include a buffer layer.

Also, the buffer layer may compensate for an optical resonance distance according to a wavelength of light emitted from the emission layer, and thus, efficiency of a formed organic light-emitting device may be improved.

The electron transport region may further include an electron blocking layer. The electron blocking layer may include, for example, mCP, but a material therefor is not limited thereto.

embedded image

Then, an emission layer may be formed on the hole transport region by vacuum deposition, spin coating, casting, LB deposition, or the like. When the emission layer is formed by vacuum deposition or spin coating, the deposition or coating conditions may be similar to those applied in forming the hole injection layer although the deposition or coating conditions may vary according to a compound that is used to form the emission layer.

Emission Layer

The organic layer 150 may include an emission layer, and the emission layer may include a host, a dopant, and a sensitizers.

The host may not include a metal atom.

The host does not emit light in the organic light-emitting device.

In an embodiment, the host may consist of one kind of a host. When the host consists of one kind of the host, the one kind of the host may be selected from an electron transport host and a hole transport host as descried below.

In one or more embodiments, the host may be a mixture of two or more different kinds of hosts. For example, the host may be a mixture of an electron transport host and a hole transport host, a mixture of two or more different kinds of electron transport hosts, or a mixture of two or more different kinds of hole transport hosts. The electron transport host and the hole transport host will be described below.

In one or more embodiments, the host may include an electron transport host including at least one electron transport moiety and a hole transport host not including an electron transport moiety.

The electron transport moiety may be selected from a cyano group, a π electron-depleted nitrogen-containing cyclic group, and a group represented by one selected from the following formulae:

embedded image

* and *′ in the formulae above each indicate a binding site to a neighboring atom.

In an embodiment, the electron transport host in the emission layer 15 may include at least one selected from a cyano group and a π electron-depleted nitrogen-containing cyclic group.

In one or more embodiments, the electron transport host in the emission layer 15 may include at least one cyano group.

In one or more embodiments, the electron transport host in the emission layer 15 may include at least one cyano group and at least one π electron-depleted nitrogen-containing cyclic group.

In one or more embodiments, the host may include an electron transport host and a hole transport host, the electron transport host may include at least one π electron-depleted nitrogen-free cyclic group and at least one electron transport moiety, and the hole transport host may include at least one π electron-depleted nitrogen-free cyclic group and may not include an electron transport moiety.

The “π electron-depleted nitrogen-containing cyclic group” as used herein indicates a cyclic group having at least one *—N═*′ moiety, and examples thereof include an imidazole group, a pyrazole group, a thiazole group, an isothiazole group, an oxazole group, an isoxazole group, a pyridine group, a pyrazine group, a pyridazine group, a pyrimidine group, an indazole group, a purine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a phthalazine group, a naphthyridine group, a quinoxaline group, a quinazoline group, a cinnoline group, a phenanthridine group, an acridine group, a phenanthroline group, a phenazine group, a benzimidazole group, an isobenzothiazole group, a benzoxazole group, an isobenzoxazole group, a triazole group, a tetrazole group, an oxadiazole group, a triazine group, a thiadiazole group, an imidazopyridine group, an imidazopyrimidine group, and an azacarbazole group.

In an embodiment, the π electron-depleted nitrogen-free cyclic group may be selected from a benzene group, a heptalene group, an indene group, a naphthalene group, an azulene group, a heptalene group, an indacene group, acenaphthylene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentacene group, a hexacene group, a pentacene group, a rubicene group, a corozene group, an ovalene group, a pyrrole group, an isoindole group, an indole group, a furan group, a thiophene group, a benzofuran group, a benzothiophene group, a benzocarbazole group, a dibenzocarbazole group, a dibenzofuran group, a dibenzothiophene group, a dibenzothiophene sulfone group, a carbazole group, a dibenzosilole group, an indeno carbazole group, an indolocarbazole group, a benzofurocarbazole group, a benzothienocarbazole group, and a triindolobenzene group, but embodiments of the present disclosure are not limited thereto.

In one or more embodiments, the electron transport host may be a group represented by Formula E-1, and

the hole transport host may be a compound represented by Formula H-1, but embodiments of the present disclosure are not limited thereto:

[Ar₃₀₁]_xb11-[(L₃₀₁)_xb1-R₃₀₁]_xb21 Formula E-1

In Formula E-1,

Ar₃₀₁may be selected from a substituted or unsubstituted C₅-C₆₀carbocyclic group and a substituted or unsubstituted C₁-C₆₀heterocyclic group,

xb11 may be 1, 2, or 3,

L₃₀₁may each independently be selected from a single bond, a group represented by one selected from the following formulae, a substituted or unsubstituted C₅-C₆₀carbocyclic group, and a substituted or unsubstituted C₁-C₆₀heterocyclic group, wherein *, *′, and *″ in the following formulae each indicate a binding site to a neighboring atom:

embedded image

xb1 may be an integer from 1 to 5,

R₃₀₁may be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C₁-C₆₀alkyl group, a substituted or unsubstituted C₂-C₆₀alkenyl group, a substituted or unsubstituted C₂-C₆₀alkynyl group, a substituted or unsubstituted C₁-C₆₀alkoxy group, a substituted or unsubstituted C₃-C₁₀cycloalkyl group, a substituted or unsubstituted C₁-C₁₀heterocycloalkyl group, a substituted or unsubstituted C₃-C₁₀cycloalkenyl group, a substituted or unsubstituted C₁-C₁₀heterocycloalkenyl group, a substituted or unsubstituted C₆-C₆₀aryl group, a substituted or unsubstituted C₆-C₆₀aryloxy group, a substituted or unsubstituted C₆-C₆₀arylthio group, a substituted or unsubstituted C₁-C₆₀heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q₃₀₁)(Q₃₀₂)(Q₃₀₃), —N(Q₃₀₁)(Q₃₀₂), —B(Q₃₀₁)(Q₃₀₂), —C(═O)(Q₃₀₁), —S(═O)₂(Q₃₀₁), —S(═O)(Q₃₀₁), —P(═O)(Q₃₀₁)(Q₃₀₂), and —P(═S)(Q₃₀₁)(Q₃₀₂),

xb21 may be an integer from 1 to 5,

Q₃₀₁to Q₃₀₃may each independently be selected from a C₁-C₁₀alkyl group, a C₁-C₁₀alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group, and

at least one selected from Condition 1 to Condition 3 may be satisfied:

Condition 1

at least one selected from Ar₃₀₁, L₃₀₁, and R₃₀₁in Formula E-1 may each independently include the π electron-depleted nitrogen-containing cyclic group

Condition 2

L₃₀₁in Formula E-1 may be a group represented by one selected from the following formulae:

embedded image

Condition 3

R₃₀₁in Formula E-1 may be selected from a cyano group, —S(═O)₂(Q₃₀₁), —S(═O)(Q₃₀₁), —P(═O)(Q₃₀₁)(Q₃₀₂), and —P(═S)(Q₃₀₁)(Q₃₀₂)

embedded image

In Formulae H-1, 11, and 12,

L₄₀₁may be selected from:

a single bond; and

a benzene group, a heptalene group, an indene group, a naphthalene group, an azulene group, a heptalene group, an indacene group, acenaphthylene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentacene group, a hexacene group, a pentacene group, a rubicene group, a corozene group, an ovalene group, a pyrrole group, an isoindole group, an indole group, a furan group, a thiophene group, a benzofuran group, a benzothiophene group, a benzocarbazole group, a dibenzocarbazole group, a dibenzofuran group, a dibenzothiophene group, a dibenzothiophene sulfone group, a carbazole group, a dibenzosilole group, an indeno carbazole group, an indolocarbazole group, a benzofurocarbazole group, a benzothienocarbazole group and a triindolobenzene group, each unsubstituted or substituted with at least one selected from deuterium, a C₁-C₁₀alkyl group, a C₁-C₁₀alkoxy group, a phenyl group, a naphthyl group, a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a triphenylenyl group, a biphenyl group, a terphenyl group, a tetraphenyl group, and —Si(Q₄₀₁)(Q₄₀₂)(Q₄₀₃),

xd1 may be an integer from 1 to 10, wherein, when xd1 is two or more, two or more of groups L₄₀₁may be identical to or different from each other,

Ar₄₀₁may be selected from groups represented by Formulae 11 and 12, Ar₄₀₂may be selected from:

groups represented by Formulae 11 and 12, a phenyl group, a naphthyl group, a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a biphenyl group, a terphenyl group, and a triphenylenyl group; and

a phenyl group, a naphthyl group, a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a biphenyl group, a terphenyl group, and a triphenylenyl group, each substituted with at least one selected from deuterium, a hydroxyl group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a naphthyl group, a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a biphenyl group, a terphenyl group, and a triphenylenyl group,

CY₄₀₁and CY₄₀₂may each independently be selected from a benzene group, a naphthalene group, a fluorene group, a carbazole group, a benzocarbazole group, an indolocarbazole group, a dibenzofuran group, a dibenzothiophene group, a dibenzosilole group, a benzonaphthofuran group, a benzonaphthothiophene group, and a benzonaphthosilole group,

A₂₁may be selected from a single bond, O, S, N(R₅₁), C(R₅₁)(R₅₂), and Si(R₅₁)(R₅₂),

A₂₂may be selected from a single bond, O, S, N(R₅₃), C(R₅₃)(R₅₄), and Si(R₅₃)(R₅₄),

in Formula 12, at least one selected from A₂₁and A₂₂may not be a single bond,

R₅₁to R₅₄, R₆₀, and R₇₀may each independently be selected from:

hydrogen, deuterium, a hydroxyl group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, and a C₁-C₂₀alkoxy group;

a C₁-C₂₀alkyl group and a C₁-C₂₀alkoxy group, each substituted with at least one selected from deuterium, a hydroxyl group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a phenyl group, a naphthyl group, a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group;

a π electron-depleted nitrogen-free cyclic group (for example, a phenyl group, a naphthyl group, a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a biphenyl group, a terphenyl group, and a triphenylenyl group) substituted with at least one selected from deuterium, a hydroxyl group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a naphthyl group, a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, a dibenzothiophenyl group, and a biphenyl group; and

—Si(Q₄₀₄)(Q₄₀₅)(Q₄₀₆),

e1 and e2 may each independently be an integer from 0 to 10,

Q₄₀₁to Q₄₀₆may each independently be selected from hydrogen, deuterium, a hydroxyl group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a phenyl group, a naphthyl group, a fluorenyl group, a carbazolyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a biphenyl group, a terphenyl group, and a triphenylenyl group, and

* indicates a binding site to a neighboring atom.

In an embodiment, in Formula E-1, Ar₃₀₁and L₃₀₁may each independently be selected from a benzene group, a naphthalene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphene group, an indenoanthracene group, a dibenzofuran group, a dibenzothiophene group, an imidazole group, a pyrazole group, a thiazole group, an isothiazole group, an oxazole group, an isoxazole group, a pyridine group, a pyrazine group, a pyridazine group, a pyrimidine group, an indazole group, a purine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a phthalazine group, a naphthyridine group, a quinoxaline group, a quinazoline group, a cinnoline group, a phenanthridine group, an acridine group, a phenanthroline group, a phenazine group, a benzimidazole group, an isobenzothiazole group, a benzoxazole group, an isobenzoxazole group, a triazole group, a tetrazole group, an oxadiazole group, a triazine group, a thiadiazole group, an imidazopyridine group, an imidazopyrimidine group, and an azacarbazole group, each unsubstituted or substituted with at least one selected from selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a cyano group-containing phenyl group, a cyano group-containing biphenyl group, a cyano group-containing terphenyl group, a cyano group-containing naphthyl group, a pyridinyl group, a phenylpyridinyl group, a diphenylpyridinyl group, a biphenylpyridinyl group, a di(biphenyl)pyridinyl group, a pyrazinyl group, a phenylpyrazinyl group, a diphenylpyrazinyl group, a biphenylpyrazinyl group, a di(biphenyl)pyrazinyl group, a pyridazinyl group, a phenylpyridazinyl group, a diphenylpyridazinyl group, a biphenylpyridazinyl group, a di(biphenyl)pyridazinyl group, a pyrimidinyl group, a phenylpyrimidinyl group, a diphenylpyrimidinyl group, a biphenylpyrimidinyl group, a di(biphenyl)pyrimidinyl group, a triazinyl group, a phenyltriazinyl group, a diphenyltriazinyl group, a biphenyltriazinyl group, a di(biphenyl)triazinyl group, —Si(Q₃₁)(Q₃₂)(Q₃₃), —N(Q₃₁)(Q₃₂), —B(Q₃₁)(Q₃₂), —C(═O)(Q₃₁), —S(═O)₂(Q₃₁), and —P(═O)(Q₃₁)(Q₃₂),

at least one selected from selected from groups L₃₀₁in the number of xb1 may each independently be selected from an imidazole group, a pyrazole group, a thiazole group, an isothiazole group, an oxazole group, an isoxazole group, a pyridine group, a pyrazine group, a pyridazine group, a pyrimidine group, an indazole group, a purine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a phthalazine group, a naphthyridine group, a quinoxaline group, a quinazoline group, a cinnoline group, a phenanthridine group, an acridine group, a phenanthroline group, a phenazine group, a benzimidazole group, an isobenzothiazole group, a benzoxazole group, an isobenzoxazole group, a triazole group, a tetrazole group, an oxadiazole group, a triazine group, a thiadiazole group, an imidazopyridine group, an imidazopyrimidine group, and an azacarbazole group, each unsubstituted or substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a cyano group-containing phenyl group, a cyano group-containing biphenyl group, a cyano group-containing terphenyl group, a cyano group-containing naphthyl group, a pyridinyl group, a phenylpyridinyl group, a diphenylpyridinyl group, a biphenylpyridinyl group, a di(biphenyl)pyridinyl group, a pyrazinyl group, a phenylpyrazinyl group, a diphenylpyrazinyl group, a biphenylpyrazinyl group, a di(biphenyl)pyrazinyl group, a pyridazinyl group, a phenylpyridazinyl group, a diphenylpyridazinyl group, a biphenylpyridazinyl group, a di(biphenyl)pyridazinyl group, a pyrimidinyl group, a phenylpyrimidinyl group, a diphenylpyrimidinyl group, a biphenylpyrimidinyl group, a di(biphenyl)pyrimidinyl group, a triazinyl group, a phenyltriazinyl group, a diphenyltriazinyl group, a biphenyltriazinyl group, a di(biphenyl)triazinyl group, —Si(Q₃₁)(Q₃₂)(Q₃₃), —N(Q₃₁)(Q₃₂), —B(Q₃₁)(Q₃₂), —C(═O)(Q₃₁), —S(═O)₂(Q₃₁), and —P(═O)(Q₃₁)(Q₃₂),

R₃₀₁may be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a tetraphenyl group, a naphthyl group, a cyano group-containing phenyl group, a cyano group-containing biphenyl group, a cyano group-containing terphenyl group, a cyano group-containing tetraphenyl group, a cyano group-containing naphthyl group, a pyridinyl group, a phenylpyridinyl group, a diphenylpyridinyl group, a biphenylpyridinyl group, a di(biphenyl)pyridinyl group, a pyrazinyl group, a phenylpyrazinyl group, a diphenylpyrazinyl group, a biphenylpyrazinyl group, a di(biphenyl)pyrazinyl group, a pyridazinyl group, a phenylpyridazinyl group, a diphenylpyridazinyl group, a biphenylpyridazinyl group, a di(biphenyl)pyridazinyl group, a pyrimidinyl group, a phenylpyrimidinyl group, a diphenylpyrimidinyl group, a biphenylpyrimidinyl group, a di(biphenyl)pyrimidinyl group, a triazinyl group, a phenyltriazinyl group, a diphenyltriazinyl group, a biphenyltriazinyl group, a di(biphenyl)triazinyl group, —Si(Q₃₁)(Q₃₂)(Q₃₃), —N(Q₃₁)(Q₃₂), —B(Q₃₁)(Q₃₂), —C(═O)(Q₃₁), —S(═O)₂(Q₃₁), and —P(═O)(Q₃₁)(Q₃₂), and

Q₃₁to Q₃₃may each independently be selected from a C₁-C₁₀alkyl group, a C₁-C₁₀alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group, but embodiments of the present disclosure are not limited thereto.

In one or more embodiments,

Ar₃₀₁may be selected from a benzene group, a naphthalene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphene group, an indenoanthracene group, a dibenzofuran group, and a dibenzothiophene group, each unsubstituted or substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a cyano group-containing phenyl group, a cyano group-containing biphenyl group, a cyano group-containing terphenyl group, a cyano group-containing naphthyl group, a pyridinyl group, a phenylpyridinyl group, a diphenylpyridinyl group, a biphenylpyridinyl group, a di(biphenyl)pyridinyl group, a pyrazinyl group, a phenylpyrazinyl group, a diphenylpyrazinyl group, a biphenylpyrazinyl group, a di(biphenyl)pyrazinyl group, a pyridazinyl group, a phenylpyridazinyl group, a diphenylpyridazinyl group, a biphenylpyridazinyl group, a di(biphenyl)pyridazinyl group, a pyrimidinyl group, a phenylpyrimidinyl group, a diphenylpyrimidinyl group, a biphenylpyrimidinyl group, a di(biphenyl)pyrimidinyl group, a triazinyl group, a phenyltriazinyl group, a diphenyltriazinyl group, a biphenyltriazinyl group, a di(biphenyl)triazinyl group, —Si(Q₃₁)(Q₃₂)(Q₃₃), —N(Q₃₁)(Q₃₂), —B(Q₃₁)(Q₃₂), —C(═O)(Q₃₁), —S(═O)₂(Q₃₁), and —P(═O)(Q₃₁)(Q₃₂); and

groups represented by Formulae 5-1 to 5-3 and 6-1 to 6-33, and

L₃₀₁may be selected from groups represented by Formulae 5-1 to 5-3 and 6-1 to 6-33:

embedded image

In Formulae 5-1 to 5-3 and 6-1 to 6-33,

Z₁may be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a cyano group-containing phenyl group, a cyano group-containing biphenyl group, a cyano group-containing terphenyl group, a cyano group-containing naphthyl group, a pyridinyl group, a phenylpyridinyl group, a diphenylpyridinyl group, a biphenylpyridinyl group, a di(biphenyl)pyridinyl group, a pyrazinyl group, a phenylpyrazinyl group, a diphenylpyrazinyl group, a biphenylpyrazinyl group, a di(biphenyl)pyrazinyl group, a pyridazinyl group, a phenylpyridazinyl group, a diphenylpyridazinyl group, a biphenylpyridazinyl group, a di(biphenyl)pyridazinyl group, a pyrimidinyl group, a phenylpyrimidinyl group, a diphenylpyrimidinyl group, a biphenylpyrimidinyl group, a di(biphenyl)pyrimidinyl group, a triazinyl group, a phenyltriazinyl group, a diphenyltriazinyl group, a biphenyltriazinyl group, a di(biphenyl)triazinyl group, —Si(Q₃₁)(Q₃₂)(Q₃₃), —N(Q₃₁)(Q₃₂), —B(Q₃₁)(Q₃₂), —C(═O)(Q₃₁), —S(═O)₂(Q₃₁), and —P(═O)(Q₃₁)(Q₃₂),

d4 may be 0, 1, 2, 3, or 4,

d3 may be 0, 1, 2, 3, or 4,

d2 may be 0, 1, 2, 3, or 4, and

* and *′ each indicate a binding site to a neighboring atom.

Q₃₁to Q₃₃may each independently be the same as described above.

In one or more embodiments, L₃₀₁may be selected from groups represented by Formulae 5-2, 5-3 and 6-8 to 6-33.

In one or more embodiments, R₃₀₁may be selected from a cyano group and groups represented by Formulae 7-1 to 7-18, wherein at least one selected from groups Ar₄₀₂in the number of xd11 may be selected from groups represented by Formulae 7-1 to 7-18, but embodiments of the present disclosure are not limited thereto:

embedded image

In Formulae 7-1 to 7-18,

xb41 to xb44 may each independently be 0, 1, or 2, xb41 in Formula 7-10 may not be 0, the sum of xb41 and xb42 in Formula e7-11 to 7-13 may not be 0, the sum of xb41, xb42, and xb43 in Formulae 7-14 to 7-16 may not be 0, the sum of xb41, xb42, xb43, and xb44 in Formulae 7-17 and 7-18 may not be 0, and * indicates a binding site to a neighboring atom.

In Formula E-1, two or more groups Ar₃₀₁may be identical to or different from each other and two or more groups L₃₀₁may be identical to or different from each other, and in Formula H-1, two or more groups L₄₀₁may be identical to or different from each other and two or more groups Ar₄₀₂may be identical to or different from each other.

In an embodiment, the electron transport host may include i) at least one selected from a cyano group, a pyrimidine group, a pyrazine group, and a triazine group and ii) a triphenylene group, and the hole transport host may include a carbazole group.

In one or more embodiments, the electron transport host may include at least one cyano group.

The electron transport host may selected from the following Compounds, but embodiments of the present disclosure are not limited thereto:

embedded image

embedded image

In an embodiment, the hole transport host may be selected from Compounds H-H1 to H-H103, but embodiments of the present disclosure are not limited thereto:

embedded image

embedded image

In one or more embodiments, the host may include an electron transport host and a hole transport host, the electron transport host may include a triphenylene group and a triazine group, and the hole transport host may include a carbazole group, but embodiments of the present disclosure are not limited thereto.

The electron transport host and the hole transport host may have a weight ratio in a range of about 1:9 to about 9:1, for example, about 2:8 to about 8:2. In an embodiment, the electron transport host and the hole transport host may have a weight ratio of about 4:6 to about 6:4. While not wishing to be bound by theory, it is understood that when the electron transport host and the hole transport host are within this weight ratio, the balance of hole and electron transport to the emission layer 15 may be achieved.

The dopant may emit light, and the light may have a decay time of about 100 nanoseconds (ns) or less. That is, since the dopant emits fluorescence, the organic light-emitting device according to an embodiment is different from the organic light-emitting device including a compound that emits phosphorescence.

A ratio of a light-emitting component emitted from the dopant to a total light-emitting component emitted from the emission layer may be about 90% or more. For example, the ratio of the light-emitting component emitted from the dopant to the total light-emitting component emitted from the emission layer may be 95% or more, 98% or more, 99% or more, or 99.9% or more, but embodiments of the present disclosure are not limited thereto.

For example, the light emitted by the dopant may have a decay time of about 20 ns or less, but embodiments of the present disclosure are not limited thereto.

The decay time of the light means the fastest value of T_decaywhen an attenuation curve of the light emitted by the dopant is fitted to Equation 1:

$\begin{matrix} f (t) = \sum_{i = 1}^{n} A_{i} \exp (- t / T_{decay, i}) . & Equation 1 \end{matrix}$

The attenuation curve of the light emitted by the dopant may be obtained by irradiating a film formed by depositing the dopant with excited light of 340 nanometers (nm) in a state in which outside air is blocked and measuring intensity of emitted light at room temperature. In order to obtain the attenuation curve, a peak wavelength of a spectrum of the dopant may be determined through a PL spectrum by using FluoTime300 (manufactured by PicoQuant) and a pumping source PLS340 (manufactured by PicoQuant) (excited wavelength=340 nm, spectral width=20 nm), and may be determined by measuring the number of photons emitted at a peak wavelength of the dopant according to the time based on Time-Correlated Single Photon Counting (TCSPC) by using FluoTime300 and PLS340.

In an embodiment, the dopant may not include a metal atom, and the dopant may satisfy Equation 2:

|D_S1−D_T1|≥2 0.3 eV. Equation 2

In Equation 2,

D_S1is a lowest excitation singlet energy level of the dopant; and

D_T1is a lowest excitation triplet energy level of the dopant.

In an embodiment, the dopant may be selected from a condensed polycyclic compound and a styryl-based compound.

For example, the dopant may include one selected from a naphthalene-containing core, a fluorene-containing core, a spiro-bifluorene-containing core, a benzofluorene-containing core, a dibenzofluorene-containing core, a phenanthrene-containing core, an anthracene-containing core, a fluoranthene-containing core, a triphenylene-containing core, a pyrene-containing core, a chrysene-containing core, a naphthacene-containing core, a picene-containing core, a perylene-containing core, a pentaphene-containing core, an indenoanthracene-containing core, a tetracene-containing core, a bisanthracene-containing core, and cores represented by Formulae 501-1 to 501-18, but embodiments of the present disclosure are not limited thereto:

embedded image

In one or more embodiments, the dopant may be selected from a styryl-amine-based compound and a styryl-carbazole-based compound, but embodiments of the present disclosure are not limited thereto.

In one or more embodiments, the dopant may be a compound represented by Formula 501:

embedded image

In Formula 501,

Ar₅₀₁may be selected from:

a naphthalene, a fluorene, a spiro-bifluorene, a benzofluorene, a dibenzofluorene, a phenanthrene, an anthracene, a fluoranthene, a triphenylene, a pyrene, a chrysene, a naphthacene, a picene, a perylene, a pentaphene an indenoanthracene, a tetracene, a bisanthracene, and groups represented by Formulae 501-1 to 501-18, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, a C₁-C₆₀alkoxy group, a C₃-C₁₀cycloalkyl group, a C₁-C₁₀heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₁-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₆-C₆₀aryloxy group, a C₆-C₆₀arylthio group, a C₁-C₆₀heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group and —Si(Q₅₀₁)(Q₅₀₂)(Q₅₀₃) (wherein Q₅₀₁to Q₅₀₃may each independently be selected from hydrogen, a C₁-C₆₀alkyl group, a C₁-C₆₀alkoxy group, a C₆-C₆₀aryl group, a C₁-C₆₀heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group),

L₅₀₁to L₅₀₃may each independently be selected from a substituted or unsubstituted C₃-C₁₀cycloalkylene group, a substituted or unsubstituted C₁-C₁₀heterocycloalkylene group, a substituted or unsubstituted C₃-C₁₀cycloalkenylene group, a substituted or unsubstituted C₁-C₁₀heterocycloalkenylene group, a substituted or unsubstituted C₆-C₆₀arylene group, a substituted or unsubstituted C₁-C₆₀heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group,

R₅₀₁and R₅₀₂may each independently be selected from:

a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a triazinyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a triazinyl group, a dibenzofuranyl group, and a dibenzothiophenyl group,

xd1 to xd3 may each independently be selected from 0, 1, 2, and 3; and

xd4 may be selected from 0, 1, 2, 3, 4, 5, and 6.

For example, in Formula 501,

Ar₅₀₁may be selected from:

a naphthalene, a fluorene, a spiro-bifluorene, a benzofluorene, a dibenzofluorene, a phenanthrene, an anthracene, a fluoranthene, a triphenylene, a pyrene, a chrysene, a naphthacene, a picene, a perylene, a pentaphene, an indenoanthracene, a tetracene, a bisanthracene, and groups represented by Formulae 501-1 to 501-18, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a carbazolyl group, a pyridinyl group, a pyrimidinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group and —Si(Q₅₀₁)(Q₅₀₂)(Q₅₀₃) (wherein Q₅₀₁to Q₅₀₃may each independently be selected from hydrogen, C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group),

L₅₀₁to L₅₀₃may each independently be the same as described in connection with L₂₁,

xd1 to xd3 may each independently be selected from 0, 1, and 2, and

xd4 may be selected from 0, 1, 2, and 3, but embodiments of the present disclosure are not limited thereto.

In one or more embodiments, the dopant may include a compound represented by one selected from Formulae 502-1 to 502-5:

embedded image

In Formulae 502-1 to 502-5,

X₅₁may be N or C-[(L₅₀₁)_xd1-R₅₀₁], X₅₂may be N or C-[(L₅₀₂)_xd2-R₅₀₂], X₅₃may be N or C-[(L₅₀₃)_xd3-R₅₀₃], X₅₄may be N or C-[(L₅₀₄)_xd4-R₅₀₄], X₅₅may be N or C-[(L₅₀₅)_xd5-R₅₀₅], X₅₆may be N or C-[(L₅₀₆)_xd6-R₅₀₆], X₅₇may be N or C-[(L₅₀₇)_xd7-R₅₀₇], and X₅₈may be N or C-[(L₅₀₈)_xd8-R₅₀₈],

L₅₀₁to L₅₀₈may each independently be the same as described in connection with L₅₀₁in Formula 501,

xd1 to xd8 may each independently be the same as described in connection with xd1 in Formula 501,

R₅₀₁to R₅₀₈may each independently be selected from:

xd11 and xd12 may each independently be an integer from 0 to 5, two selected from R₅₀₁to R₅₀₄may optionally be linked to form a saturated or unsaturated ring,

two selected from R₅₀₅to R₅₀₈may optionally be linked to form a saturated or unsaturated ring.

In one or more embodiments, the dopant may include a compound represented by Formula 503:

embedded image

In Formula 503,

R₅₀₁to R₅₀₇and R₅₁₁to R₅₁₆may each independently be selected from:

two selected from R₅₁₃to R₅₁₆may optionally be linked to form a saturated ring.

The dopant may include, for example, at least one selected from selected from Compounds FD(1) to FD(16) and FD1 to FD13:

embedded image

In the emission layer, an amount of the dopant material may be in a range of about 0.01 parts to about 15 parts by weight based on 100 parts by weight of the host material, but embodiments of the present disclosure are not limited thereto.

The sensitizer may include the organometallic compound represented by one selected from Formulae 1 and 2:

embedded image

In Formulae 1 and 2, M₁₁and M₁₂may each independently be selected from beryllium (Be), magnesium (Mg), aluminum (Al), calcium (Ca), titanium (Ti), manganese (Mn), cobalt (Co), copper (Cu), zinc (Zn), gallium (Ga), germanium (Ge), zirconium (Zr), ruthenium (Ru), rhodium (Rh), palladium (Pd), silver (Ag), rhenium (Re), platinum (Pt), gold (Au), iridium (Ir), osmium (Os), hafnium (Hf), europium (Eu), terbium (Tb), and thulium (Tm).

For example, in Formulae 1 and 2, M₁₁and M₁₂may each independently be selected from Pt, Pd, Cu, Au, Ir, Ru, Os, and Re, but embodiments of the present disclosure are not limited thereto.

In an embodiment, in Formulae 1 and 2, M₁₁and M₁₂may each independently be selected from Pt and Pd, but embodiments of the present disclosure are not limited thereto.

In Formulae 1 and 2, A₁₁to A₁₄and A₂₁to A₂₄may each independently be selected from a C₅-C₆₀carbocyclic group and a C₁-C₆₀heterocyclic group.

For example, in Formulae 1 and 2, A₁₁to A₁₄and A₂₁to A₂₄may each independently be selected from a) a 6-membered ring, b) a condensed ring in which at least two 6-membered rings are condensed, and c) a condensed ring in which at least one 6-membered ring is condensed with one 5-membered ring,

the 6-membered ring may be selected from a cyclohexane group, a cyclohexene group, a cyclohexadiene group, an adamantane group, a norbornane group, a norbornene group, a benzene group, a pyridine group, a dihydropyridine group, a tetrahydropyridine group, a pyrimidine group, a dihydropyrimidine group, a tetrahydropyrimidine group, a pyrazine group, a dihydropyrazine group, a tetrahydropyrazine group, a pyridazine group, a dihydropyridazine group, a tetrahydropyridazine group, and a triazine group,

the 5-membered ring may be selected from a cyclopentane group, a cyclopentene group, a cyclopentadiene group, a furan group, a thiophene group, a silole group, a pyrrole group, a pyrazole group, an imidazole group, a triazole group, a 2,3-dihydroimidazole group, a 2,3-dihydrotriazole group, an oxazole group, an isoxazole group, a thiazole group, an isothiazole group, an oxadiazole group, and a thiadiazole group, but embodiments of the present disclosure are not limited thereto.

In an embodiment, in Formulae 1 and 2, A₁₁to A₁₄and A₂₁to A₂₄may each independently be selected from a benzene group, a naphthalene group, an anthracene group, a phenanthrene group, a triphenylene group, a pyrene group, a chrysene group, a cyclopentadiene group, a 1,2,3,4-tetrahydronaphthalene group, a furan group, a thiophene group, a silole group, an indene group, a fluorene group, an indole group, a carbazole group, a benzofuran group, a dibenzofuran group, a benzothiophene group, a dibenzothiophene group, a benzosilole group, a dibenzosilole group, an indeno pyridine group, an indolopyridine group, a benzofuropyridine group, a benzothienopyridine group, a benzosilolopyridine group, an indeno pyrimidine group, an indolopyrimidine group, a benzofuropyrimidine group, a benzothienopyrimidine group, a benzosilolopyrimidine group, a dihydropyridine group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a quinoline group, an isoquinoline group, a quinoxaline group, a quinazoline group, a cinnoline group, a phthalazine group, a phenanthroline group, a pyrrole group, a pyrazole group, an imidazole group, a 2,3-dihydroimidazole group, a triazole group, a 2,3-dihydrotriazole group, an oxazole group, an isoxazole group, a thiazole group, an isothiazole group, an oxadiazole group, a thiadiazole group, a benzopyrazole group, a benzimidazole group, a 2,3-dihydrobenzimidazole group, an imidazopyridine group, a 2,3-dihydroimidazopyridine group, an imidazopyrimidine group, a 2,3-dihydroimidazopyrimidine group, an imidazopyrazine group, a 2,3-dihydroimidazopyrazine group, a benzoxazole group, a benzothiazole group, a benzoxadiazole group, a benzothiadiazole group, a 1,2,3,4-tetrahydroisoquinoline group, a 1,2,3,4-tetrahydroquinoline group, a 1,2,3,4-tetrahydrophthalazine group, and a 1,2,3,4-tetrahydrocinnoline group, but embodiments of the present disclosure are not limited thereto.

In an embodiment, A₁₁to A₁₄and A₂₁to A₂₄may each independently be selected from a benzene group, a naphthalene group, an anthracene group, a phenanthrene group, a triphenylene group, a pyrene group, a chrysene group, a cyclopentadiene group, a 1,2,3,4-tetrahydronaphthalene group, a fluorene group, a carbazole group, a dibenzofuran group, a dibenzothiophene group, a dibenzosilole group, an indeno pyridine group, an indolopyridine group, a benzofuropyridine group, a benzothienopyridine group, a benzosilolopyridine group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a quinoline group, an isoquinoline group, a quinoxaline group, a quinazoline group, a phenanthroline group, a cinnoline group, a phthalazine group, a 1,2,3,4-tetrahydroisoquinoline group, a 1,2,3,4-tetrahydroquinoline group, a 1,2,3,4-tetrahydrophthalazine group, and a 1,2,3,4-tetrahydrocinnoline group, but embodiments of the present disclosure are not limited thereto.

In Formulae 1 and 2, Y₁₁to Y₁₄and Y₂₁to Y₂₄may each independently be selected from N and C.

In Formulae 1 and 2, T₁₁to T₁₄may each independently be selected from a covalent bond, a coordinate bond, O, S, N(R₁₅), P(R₁₅), B(R₁₅), C(R₁₅)(R₁₆), and Si(R₁₅)(R₁₆), and T₂₁to T₂₄may each independently be selected from a covalent bond, a coordinate bond, O, S, N(R₂₅), P(R₂₅), B(R₂₅), C(R₂₅)(R₂₆), and Si(R₂₅)(R₂₆).

For example, in Formulae 1 and 2, T₁₁to T₁₄and T₂₁to T₂₄may each independently be selected from a covalent bond, a coordinate bond, O, and S, but embodiments of the present disclosure are not limited thereto.

In Formulae 1 and 2, L₁₁to L₁₃may each independently be selected from *—O—*′, *—S—*′, *—C(R₁₇)(R₁₈)—*′, *—C(R₁₇)═*′, *═C(R₁₇)—*′, *—C(R₁₇)═C(R₁₈)—*′, *—C(═O)—*, *—C(═S)—*′, *—C≡C—*′, *—B(R₁₇)—*′, *—N(R₁₇)—*′, *—P(R₁₇)—*′, *—Si(R₁₇)(R₁₈)—*′, *—P(R₁₇)(R₁₈)—*′, and *—Ge(R₁₇)(R₁₈)—*′, and

For example, in Formulae 1 and 2, L₁₁to L₁₃may each independently be selected from *—O—*′, *—S—*′, *—C(R₁₇)(R₁₈)—*′, and *—N(R₁₇)—*′, and L₂₁to L₂₄may each independently be selected from *—O—*′, *—S—*′, *—C(R₂₇)(R₂₈)—*′, and *—N(R₂₇)—*′, but embodiments of the present disclosure are not limited thereto.

In Formulae 1 and 2, a11 to a13 and a21 to a24 may each independently be selected from 0 and 1.

For example, in Formulae 1 and 2, the sum of a11 to a13 may be selected from 0, 1, 2, and 3, the sum of a21 to a24 may be selected from 0, 1, 2, 3, and 4, but embodiments of the present disclosure are not limited thereto.

In an embodiment, in Formulae 1 and 2, the sum of a11 to a13 may be selected from 0 and 1, and the sum of a21 to a24 may be selected from 0 and 1, but embodiments of the present disclosure are not limited thereto.

In Formulae 1 and 2, when a11 is 0, (L₁)_a11may be a covalent bond, when a12 is 0, (L₁₂)_a12may be a covalent bond, when 13 is 0, (L₁₃)_a13may be a covalent bond, when a21 is 0, (L₂₁)_a21may be a covalent bond, when a22 is 0, (L₂₂)_a22may be a covalent bond, when a23 is 0, (L₂₃)_a23may be a covalent bond, and when a24 is 0, (L₂₄)_a24may be a covalent bond.

In Formulae 1 and 2, L₁₅to L₁₈and L₂₅to L₂₈may each independently be selected from a substituted or unsubstituted C₅-C₃₀carbocyclic group and a substituted or unsubstituted C₁-C₃₀heterocyclic group.

For example, in Formulae 1 and 2, L₁₅to L₁₈and L₂₅to L₂₈may each independently be selected from a benzene group, a naphthalene group, an anthracene group, a phenanthrene group, a triphenylene group, a pyrene group, a chrysene group, a cyclopentadiene group, a furan group, a thiophene group, a silole group, an indene group, a fluorene group, an indole group, a carbazole group, a benzofuran group, a dibenzofuran group, a benzothiophene group, a dibenzothiophene group, a benzosilole group, a dibenzosilole group, an azafluorene group, an azacarbazole group, an azadibenzofuran group, an azadibenzothiophene group, an azadibenzosilole group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a quinoline group, an isoquinoline group, a quinoxaline group, a quinazoline group, a phenanthroline group, a pyrrole group, a pyrazole group, an imidazole group, a triazole group, an oxazole group, an isoxazole group, a thiazole group, an isothiazole group, an oxadiazole group, a thiadiazole group, a benzopyrazole group, a benzimidazole group, a benzoxazole group, a benzothiazole group, a benzoxadiazole group, and a benzothiadiazole group; and

a benzene group, a naphthalene group, an anthracene group, a phenanthrene group, a triphenylene group, a pyrene group, a chrysene group, a cyclopentadiene group, a furan group, a thiophene group, a silole group, an indene group, a fluorene group, an indole group, a carbazole group, a benzofuran group, a dibenzofuran group, a benzothiophene group, a dibenzothiophene group, a benzosilole group, a dibenzosilole group, an azafluorene group, an azacarbazole group, an azadibenzofuran group, an azadibenzothiophene group, an azadibenzosilole group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a quinoline group, an isoquinoline group, a quinoxaline group, a quinazoline group, a phenanthroline group, a pyrrole group, a pyrazole group, an imidazole group, a triazole group, an oxazole group, an isoxazole group, a thiazole group, an isothiazole group, an oxadiazole group, a thiadiazole group, a benzopyrazole group, a benzimidazole group, a benzoxazole group, a benzothiazole group, a benzoxadiazole group and a benzothiadiazole group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a naphthyl group, a pyridinyl group, a pyrimidinyl group, a triazinyl group, a fluorenyl group, a dimethylfluorenyl group, a diphenyl fluorenyl group, a carbazolyl group, a phenylcarbazolyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a dibenzosilolyl group, a dimethyl dibenzosilolyl group, a diphenyl dibenzosilolyl group, —N(Q₃₁)(Q₃₂), —Si(Q₃₃)(Q₃₄)(Q₃₅), —B(Q₃₆)(Q₃₇), and —P(═O)(Q₃₈)(Q₃₉), and

Q₃₁to Q₃₉may each independently be selected from:

—CH₃, —CD₃, —CD₂H, —CDH₂, —CH₂CH₃, —CH₂CD₃, —CH₂CD₂H, —CH₂CDH₂, —CHDCH₃, —CHDCD₂H, —CHDCDH₂, —CHDCD₃, —CD₂CD₃, —CD₂CD₂H, and —CD₂CDH₂;

an n-propyl group, an iso-propyl group, an n-butyl group, an iso-butyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an iso-pentyl group, a sec-pentyl group, a tert-pentyl group, a phenyl group, and a naphthyl group; and an n-propyl group, an iso-propyl group, an n-butyl group, an iso-butyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an iso-pentyl group, a sec-pentyl group, a tert-pentyl group, a phenyl group, and a naphthyl group, each substituted with at least one selected from deuterium, a C₁-C₁₀alkyl group, and a phenyl group.

In an embodiment, in Formulae 1 and 2, L₁₅to L₁₈and L₂₅to L₂₈may each independently be selected from:

a benzene group, a pyridine group, and a pyrimidine group; and

a benzene group, a pyridine group, and a pyrimidine group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a phenyl group, a pyridinyl group, and a pyrimidinyl group, —N(Q₃₁)(Q₃₂), —Si(Q₃₃)(Q₃₄)(Q₃₅), —B(Q₃₆)(Q₃₇), and —P(═O)(Q₃₈)(Q₃₉) (wherein Q₃₁to Q₃₉may each independently be the same as described above), but embodiments of the present disclosure are not limited thereto.

In Formulae 1 and 2, a15 to a18 and a25 to a28 may each independently be selected from 0, 1, 2, 3, 4, and 5.

For example, in Formulae 1 and 2, a15 to a18 and a25 to a28 may each independently be selected from 0 and 1, but embodiments of the present disclosure are not limited thereto.

In Formulae 1 and 2, R₁₁to R₁₈and R₂₁to R₂₈may each independently be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, —SF₅, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C₁-C₆₀alkyl group, a substituted or unsubstituted C₂-C₆₀alkenyl group, a substituted or unsubstituted C₂-C₆₀alkynyl group, a substituted or unsubstituted C₁-C₆₀alkoxy group, a substituted or unsubstituted C₃-C₁₀cycloalkyl group, a substituted or unsubstituted C₁-C₁₀heterocycloalkyl group, a substituted or unsubstituted C₃-C₁₀cycloalkenyl group, a substituted or unsubstituted C₁-C₁₀heterocycloalkenyl group, a substituted or unsubstituted C₆-C₆₀aryl group, a substituted or unsubstituted C₇-C₆₀alkylaryl group, a substituted or unsubstituted C₆-C₆₀aryloxy group, a substituted or unsubstituted C₆-C₆₀arylthio group, a substituted or unsubstituted C₁-C₆₀heteroaryl group, a substituted or unsubstituted C₂-C₆₀alkylheteroaryl group, a substituted or unsubstituted C₁-C₆₀heteroaryloxy group, a substituted or unsubstituted C₁-C₆₀heteroarylthio group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q₁)(Q₂)(Q₃), —B(Q₁)(Q₂), —N(Q₁)(Q₂), —P(Q₁)(Q₂), —C(═O)(Q₁), —S(═O)(Q₁), —S(═O)₂(Q₁), —P(═O)(Q₁)(Q₂), and —P(═S)(Q₁)(Q₂),

Q₁to Q₃may each independently be selected hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, a C₁-C₆₀alkoxy group, a C₃-C₁₀cycloalkyl group, a C₁-C₁₀heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₁-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₆-C₆₀aryloxy group, a C₆-C₆₀arylthio group, a C₁-C₆₀heteroaryl group, a C₂-C₆₀alkylheteroaryl group, a C₁-C₆₀heteroaryloxy group, a C₁-C₆₀heteroarylthio group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a C₁-C₆₀alkyl group substituted with at least one selected from deuterium, —F, a cyano group, a C₁-C₆₀alkyl group, and a C₆-C₆₀aryl group, and a C₆-C₆₀aryl group substituted with at least one selected from selected from deuterium, —F, a cyano group, a C₁-C₆₀alkyl group, and a C₆-C₆₀aryl group.

For example, in Formulae 1 and 2, R₁₁to R₁₈and R₂₁to R₂₈may each independently be selected from:

a C₁-C₂₀alkyl group and a C₁-C₂₀alkoxy group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H, —CFH₂, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₁₀alkyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cycloctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a naphthyl group, a pyridinyl group, and a pyrimidinyl group;

a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cycloctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a dibenzosilolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group, and an imidazopyrimidinyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H, —CFH₂, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₂₀alkyl group, a C₁-C₂₀alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cycloctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a dibenzosilolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, and —Si(Q₃₃)(Q₃₄)(Q₃₅); and

—N(Q₁)(Q₂), —Si(Q₃)(Q₄)(Q₅), —B(Q₆)(Q₇), and —P(═O)(Q₈)(Q₉),

Q₁to Q₉and Q₃₃to Q₃₅may each independently be selected from:

an n-propyl group, an iso-propyl group, an n-butyl group, an iso-butyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an iso-pentyl group, a sec-pentyl group, a tert-pentyl group, a phenyl group, and a naphthyl group, each substituted with at least one selected from deuterium, a C₁-C₁₀alkyl group, and a phenyl group,

but embodiments of the present disclosure are not limited thereto.

In an embodiment, in Formulae 1 and 2, R₁₁to R₁₈and R₂₁to R₂₈may each independently be selected from hydrogen, deuterium, —F, a cyano group, a nitro group, —SF₅, —CH₃, —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H, —CFH₂, groups represented by Formulae 9-1 to 9-21, groups represented by Formulae 10-1 to 10-253, —N(Q₁)(Q₂), —Si(Q₃)(Q₄)(Q₅), —B(Q₆)(Q₇), and —P(═O)(Q₈)(Q₉), but embodiments of the present disclosure are not limited thereto:

embedded image

embedded image

embedded image

Q₁to Q₉may each independently be selected from:

—CH₃, —CD₃, —CD₂H, —CDH₂, —CH₂CH₃, —CH₂CD₃, —CH₂CD₂H, —CH₂CDH₂, —CHDCH₃, —CHDCD₂H, —CHDCDH₂, —CHDCD₃, —CD₂CD₃, —CD₂CD₂H and —CD₂CDH₂;

an n-propyl group, an iso-propyl group, an n-butyl group, an iso-butyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an iso-pentyl group, a sec-pentyl group, a tert-pentyl group, a phenyl group, and a naphthyl group, each substituted with at least one selected from deuterium, a C₁-C₁₀alkyl group, and a phenyl group.

In Formulae 9-1 to 9-21 and 10-1 to 10-253,

* indicates a binding site to a neighboring atom,

i-Pr is an iso-propyl group, and t-Bu is a t-butyl group,

Ph is a phenyl group,

1-Nph is a 1-naphthyl group, and 2-Nph is a 2-naphthyl group,

2-Pyr is a 2-pyridyl group, 3-Pyr is a 3-pyridyl group, and 4-Pyr is a 4-pyridyl group, and

TMS is a trimethylsilyl group.

In Formulae 1 and 2, b11 to b14 and b21 to b24 may each independently be selected from 1, 2, 3, 4, and 5.

In Formulae 1 and 2, n11 to n14 and n21 to n24 may each independently be selected from 1, 2, 3, 4, 5, 6, 7, and 8.

For example, in Formulae 1 and 2, n11 to n14 and n21 to n24 may each be 1, but embodiments of the present disclosure are not limited thereto.

In an embodiment, the sensitizer may be represented by one selected from Formulae 1A and 1B:

embedded image

In Formulae 1A and 1B,

M₁₁, A₁₁to A₁₄, Y₁₁to Y₁₄, T₁₄, L₁₁, L₁₅to L₁₈, a15 to a18, R₁₁to R₁₄, b11 to b14, and n11 to n14 may each independently be the same as described in Formula 1,

T₁₄may be selected from O and S,

Y₁₅to Y₁₇may each independently be selected from C and N,

Y₁₈may be selected from O, S, N(R₁₉), C(R₁₉)(R₂₀), Si(R₁₉)(R₂₀), Ge(R₁₉)(R₂₀), C(═O), N, C(R₁₉), Si(R₁₉), and Ge(R₁₉),

A₁₅and A₁₆may each independently be selected from a C₅-C₃₀carbocyclic group and a C₁-C₃₀heterocyclic group, and

R₁₉and R₂₀may each independently be the same as described in connection with R₁₁in Formula 1.

In one or more embodiments, the sensitizer may be represented by one selected from Formulae 1A-1 and 1B-1:

embedded image

In Formulae 1A-1 and 1B-1,

M₁₁, Y₁₁to Y₁₃, and L₁₁may each independently be the same as described in Formula 1,

Z_11amay be selected from N and C[(L_15a)_a15a-(R_11a)_b11a]_n11a, Z_11bmay be selected from N and C[(L_15b)_a15b-(R_11b)_b11b]_n11b, Z_11cmay be selected from N and C[(L_15c)_a15c-(R_11c)_b11c]_n11c, and Z_11dmay be selected from N and C[(L_15d)_a15d-(R_11d)_b11d]_n11d,

Z_12amay be selected from N and C[(L_16a)_a16a-(R_12a)_b12a]_n12a, Z_12bmay be selected from N and C[(L_16b)_a16b-(R_12b)_b12b]_n12b, and Z_12cmay be selected from N and C[(L_16c)_a16c-(R_12c)_b12c]_n12c,

Z_13amay be selected from N and C[(L_17a)_a17a-(R_13a)_b13a]_n13a, Z_13bmay be selected from N and C[(L_17b)_a17b-(R_13b)_b13b]_n13b, and Z_13cmay be selected from N and C[(L_17c)_a17c-(R_13c)_b13c]_n13c,

Z_14amay be selected from N and C[(L_18a)_a18a-(R_14a)_b14a]_n14a, Z_14bmay be selected from N and C[(L_18b)_a18b-(R_14b)_b14b]_n14b, Z_14cmay be selected from N and C[(L_18c)_a18c-(R_14c)_b14c]_n14c, and Z_14dmay be selected from N and C[(L_18d)_a18d-(R_14d)_b14d]_n14d,

L_15ato L_15d, a15a to a15d, R_11ato R_11d, b11a to b11d, and n11a to n11d may each independently be the same as described in connection with L₁₅, a15, R₁₁, b11, and n11 in Formula 1,

L_16ato L_16c, a16a to a16c, R_12ato R_12c, b12a to b12c, and n12a to n12c may each independently be the same as described in connection with L₁₆, a16, R₁₂, b12, and n12 in Formula 1,

L_17ato L_17c, a17a to a17c, R_13ato R_13c, b13a to b13c, and n13a to n13c may each independently be the same as described in connection with L₁₇, a17, R₁₃, b13, and n13 in Formula 1,

L_18ato L_18d, a18a to a18d, R_14ato R_14d, b14a to b14d, and n14a to n14d may each independently be the same as described in connection with L₁₈, a18, R₁₄, b14, and

n14 in Formula 1,

T₁₄may be selected from O and S,

Y₁₅may be selected from C and N,

Y₁₈may be selected from O, S, N(R₁₉), C(R₁₉)(R₂₀), Si(R₁₉)(R₂₀), Ge(R₁₉)(R₂₀), C(═O), N, C(R₁₉), Si(R₁₉), and Ge(R₁₉), and

R₁₉and R₂₀may each independently be the same as described in connection with R₁₁in Formula 1.

In one or more embodiments, the sensitizer may be one selected from Compounds 1-1 to 1-88, 2-1 to 2-47, 3-1 to 3-582, and 4-1 to 4-333, but embodiments of the present disclosure are not limited thereto:

embedded image

embedded image

embedded image

embedded image

embedded image

embedded image

embedded image

embedded image

The sensitizer does not emit light within the organic light-emitting device. Therefore, the organic light-emitting device according to the embodiment is different from the organic light-emitting device in which the compound represented by one selected from Formulae 1 and 2 emits light.

Although the sensitizer does not emit light within the organic light-emitting device, intersystem crossing (ICS) actively occurs in the sensitizer, and thus, singlet exciton generated in the host may be transferred to the dopant.

Energy transition of the organic light-emitting device according to the embodiment will be described in detail with reference to FIG. 2. The singlet exciton having a ratio of 25% generated in the host is transferred to the singlet of the sensitizer and transitions to the triplet of the sensitizer due to intersystem crossing in the sensitizer. Then, the exciton that transitions to the triplet of the sensitizer is transferred to the singlet of the dopant. Thus, light may be emitted from the dopant. In addition, the triplet exciton having ratio of 75% generated in the host is transferred to the triplet of the sensitizer and transferred again to the singlet of the dopant. Thus, light may be emitted from the dopant. Since both the singlet exciton and the triplet exciton generated in the emission layer are transferred to the dopant, an organic light-emitting device having improved efficiency may be obtained. In addition, since an organic light-emitting device having remarkably reduced loss is obtained, lifespan characteristics of the organic light-emitting device may be improved.

Since the organic light-emitting device essentially includes the sensitizer represented by one selected from Formulae 1 and 2, the efficiency and lifespan of the organic light-emitting device may be improved. Specifically, since the sensitizer represented by one selected from Formulae 1 and 2 has excellent characteristics in terms of exciton transfer to the dopant, the organic light-emitting device has improved efficiency and lifespan, as compared with an organic light-emitting device including a compound such as Ir(ppy)₃.

An amount of the sensitizer in the emission layer may be in a range of about 5 percent by weight (wt %) to about 20 wt %. While not wishing to be bound by theory, it is understood that when the amount of the sensitizer is within this range, it is possible to achieve effective energy transfer in the emission layer. Therefore, it is possible to implement an organic light-emitting device having high efficiency and a long lifespan.

In an embodiment, the host, the dopant, and the sensitizer may further satisfy Equation 3 below:

H
_T1
>S
_T1
>D
_S1. Equation 3

In Equation 3,

H_T1is a lowest excitation triplet energy level of the host;

D_S1is a lowest excitation singlet energy level of the dopant; and

S_T1is a lowest excitation triplet energy level of the sensitizer.

While not wishing to be bound by theory, it is understood that when the host, the dopant, and the sensitizer further satisfy Equation 3, the triplet exciton is transferred from the emission layer to the dopant, thereby obtaining an organic light-emitting device having improved efficiency.

In an embodiment, the host and the sensitizer may further satisfy Equation 4 below:

H
_T1
−S
_T1>10 meV. Equation 4

In Equation 4,

H_T1is a lowest excitation triplet energy level of the host; and

S_T1is a lowest excitation triplet energy level of the sensitizer.

While not wishing to be bound by theory, it is understood that when the host and the sensitizer further satisfy Equation 4, the triplet exciton of the host is effectively transferred to the sensitizer, thereby obtaining an organic light-emitting device having improved efficiency.

In an embodiment, the dopant and the sensitizer may further satisfy Equation 5 below:

S
_T1
−D
_S1>10 meV. Equation 5

In Equation 5,

S_T1is a lowest excitation triplet energy level of the sensitizer; and

D_S1is a lowest excitation singlet energy level of the dopant.

While not wishing to be bound by theory, it is understood that when the dopant and the sensitizer further satisfy Equation 5, the triplet exciton of the sensitizer is efficiently transferred to the dopant, thereby obtaining an organic light-emitting device having improved efficiency.

A thickness of the emission layer may be in a range of about 100 Å to about 1,000 Å, for example, about 200 Å to about 600 Å. While not wishing to be bound by theory, it is understood that when the thickness of the emission layer is within this range, excellent light-emission characteristics may be obtained without a substantial increase in driving voltage.

When the organic light-emitting device is a full-color organic light-emitting device, the emission layer may be patterned into a red emission layer, a green emission layer, and a blue emission layer. In one or more embodiments, due to a stacked structure including a red emission layer, a green emission layer, and/or a blue emission layer, the emission layer may emit white light.

Then, an electron transport region may be disposed on the emission layer.

The electron transport region may include a hole blocking layer, an electron transport layer, an electron injection layer, or any combination thereof.

For example, the electron transport region may have a hole blocking layer/electron transport layer/electron injection layer structure or an electron transport layer/electron injection layer structure, but the structure of the electron transport region is not limited thereto. The electron transport layer may have a single-layered structure or a multi-layered structure including two or more different materials.

Conditions for forming the hole blocking layer, the electron transport layer, and the electron injection layer which constitute the electron transport region may be understood by referring to the conditions for forming the hole injection layer.

When the electron transport region includes a hole blocking layer, the hole blocking layer may include, for example, at least one of BCP and Bphen, but may also include other materials.

embedded image

For example, as a material for the hole blocking layer, the first compound represented by Formula 1 may be used, but embodiments of the present disclosure are not limited thereto.

A thickness of the hole blocking layer may be in a range of about 20 Å to about 1,000 Å, for example, about 30 Å to about 300 Å. While not wishing to be bound by theory, it is understood that when the thickness of the hole blocking layer is within these ranges, the hole blocking layer may have excellent hole blocking characteristics without a substantial increase in driving voltage.

The electron transport layer may further include, in addition to the organometallic compound represented by Formula 1, at least one selected from BCP, Bphen, Alq₃, BAlq, TAZ, and NTAZ.

embedded image

In one or more embodiments, the electron transport layer may include at least one of ET1 and ET25, but are not limited thereto:

embedded image

A thickness of the electron transport layer may be in a range of about 100 Å to about 1,000 Å, for example, about 150 Å to about 500 Å. While not wishing to be bound by theory, it is understood that when the thickness of the electron transport layer is within this range, the electron transport layer may have satisfactory electron transport characteristics without a substantial increase in driving voltage.

In addition, the electron transport layer may further include, in addition to the materials described above, a metal-containing material.

The metal-containing material may include a Li complex. The Li complex may include, for example, Compound ET-D1 (lithium 8-hydroxyquinolate, LiQ) or ET-D2:

embedded image

The electron transport region may include an electron injection layer (EIL) that promotes flow of electrons from the second electrode 19 thereinto.

The electron injection layer may include at least one selected from LiF, NaCl, CsF, Li₂O, and BaO.

A thickness of the electron injection layer may be in a range of about 1 Å to about 1,000 Å, for example, about 3 Å to about 90 Å. While not wishing to be bound by theory, it is understood that when the thickness of the electron injection layer is within this range, the electron injection layer may have satisfactory electron injection characteristics without a substantial increase in driving voltage.

The second electrode 19 may be disposed on the organic layer 15. The second electrode 19 may be a cathode. A material for forming the second electrode 19 may be metal, an alloy, an electrically conductive compound, or a combination thereof, which has a relatively low work function. For example, lithium (Li), magnesium (Mg), aluminum (Al), aluminum-lithium (Al—Li), calcium (Ca), magnesium-indium (Mg—In), or magnesium-silver (Mg—Ag) may be formed as the material for forming the second electrode 19. To manufacture a top-emission type light-emitting device, a transmissive electrode formed using ITO or IZO may be used as the second electrode 19.

Hereinbefore, the organic light-emitting device has been described with reference to FIG. 1, but embodiments of the present disclosure are not limited thereto.

Description of FIG. 3

FIG. 3 is a schematic view of an organic light-emitting device 100 according to an embodiment.

An organic light-emitting device 100 of FIG. 3 may include a first electrode 110, a second electrode 190 facing the first electrode 110, and a first light-emitting unit 151 and a second light-emitting unit 152 disposed between the first electrode 100 and the second electrode 190. A charge generation layer 141 may be disposed between the first light-emitting unit 151 and a second light-emitting unit 152, and the charge generation layer 141 includes an n-type charge generation layer 141-N and a p-type charge generation layer 141-P. The charge generation layer 141 may generate charges and supply the generated charges to neighboring light-emitting units and may use a known material.

The first light-emitting unit 151 may include a first emission layer 151-EM, and the second light-emitting unit 152 includes a second emission layer 152-EM. A maximum emission wavelength of light emitted by the first light-emitting unit 151 may be different from a maximum emission wavelength of light emitted by the second light-emitting unit 152. For example, mixed light of the light emitted by the first light-emitting unit 151 and the light emitted by the second light-emitting unit 152 may be white light, but embodiments of the present disclosure are not limited thereto.

A hole transport region 120 may be disposed between the first light-emitting unit 151 and the first electrode 110, and the second light-emitting unit 152 may include a first transport region 121 disposed to be close to the first electrode 110.

An electronic region 170 may be disposed between the second light-emitting unit 152 and the second electrode 190, and the first light-emitting unit 151 may include a first electron transport region 171 disposed between the charge generation layer 141 and the first emission layer 151-EM.

The first emission layer 151-EM may include a host, a dopant, and a sensitizer. The host does not include a metal atom. The dopant may emit light, and the light may have a decay time of about 100 ns or less. The sensitizer may include an organometallic compound represented by one selected from Formulae 1 and 2.

The second emission layer 152-EM may include a host, a dopant, and a sensitizer. The host does not include a metal atom. The dopant may emit light, and the light may have a decay time of about 100 ns or less. The sensitizer may include an organometallic compound represented by one selected from Formulae 1 and 2.

The first electrode 110 and the second electrode 190 in FIG. 3 are the same as described in connection with the first electrode 11 and the second electrode 19 in FIG. 1.

The first emission layer 151-EM and the second emission layer 152-EM in FIG. 3 are the same as described in connection with the emission layer 15 in FIG. 3.

The hole transport region 120 and the first hole transport region 121 in FIG. 3 are the same as described in connection with the hole transport region 12 in FIG. 1.

The electron transport region 170 and the first electron transport region 171 in FIG. 3 are the same as described in connection with the electron transport region 17 in FIG. 1.

Hereinbefore, the first light-emitting unit 151 and the second light-emitting unit 152 have been described in connection with the organic light-emitting device including the emission layer including the host, the dopant, and the sensitizer with reference to FIG. 3, one of the first light-emitting unit 151 and the second light-emitting unit 152 of the organic light-emitting device in FIG. 3 may be replaced with an arbitrary known light-emitting unit or may include three or more light-emitting units. In this manner, other modifications may be possible.

Description of FIG. 4

FIG. 4 is a schematic view of an organic light-emitting device 200 according to another embodiment.

The organic light-emitting device 200 may include a first electrode 210, a second electrode 290 facing the first electrode 210, and a first emission layer 251 and a second emission layer 252 stacked between the first electrode 210 and the second electrode 290.

A maximum emission wavelength of light emitted by the first emission layer 251 may be different from a maximum emission wavelength of light emitted by the second emission layer 252. For example, mixed light of the light emitted by the first emission layer 251 and the light emitted by the second emission layer 252 may be white light, but embodiments of the present disclosure are not limited thereto.

Meanwhile, a hole transport region 220 may be disposed between the first emission layer 251 and the first electrode 210, and an electron transport region 270 may be disposed between the second emission layer 252 and the second electrode 290.

The first emission layer 251 may include a host, a dopant, and a sensitizer. The host does not include a metal atom. The dopant may emit light, and the light may have a decay time of about 100 ns or less. The sensitizer may include an organometallic compound represented by one selected from Formulae 1 and 2.

The second emission layer 252 may include a host, a dopant, and a sensitizer. The host does not include a metal atom. The dopant may emit light, and the light may have a decay time of about 100 ns or less. The sensitizer may include an organometallic compound represented by one selected from Formulae 1 and 2.

The first electrode 210, the hole transport region 220, and the second electrode 290 in FIG. 4 are the same as described in connection with the first electrode 11, the hole transport region 12, and the second electrode 19 in FIG. 1.

The first emission layer 251 and the second emission layer 252 in FIG. 4 are the same as described in connection with the emission layer 15 in FIG. 1.

The electron transport region 270 in FIG. 1 is the same as described in connection with the electron transport region 17 in FIG. 1.

Hereinbefore, the first emission layer 251 and the second emission layer 252 have been described in connection with the organic light-emitting device including the host, the dopant, and the sensitizer with reference to FIG. 4, one of the first emission layer 251 and the second emission layer 252 in FIG. 4 may be replaced with a known layer or may include three or more emission layers, and an intermediate layer may be disposed between neighboring emission layers. In this manner, other modifications may be possible.

The first-row transition metal of the Periodic Table of Elements means an element included in a d-block while being a fourth-row element of the Periodic Table of Elements. Specific examples include scandium (Sc), titanium (Ti), vanadium (V), chromium (Cr), manganese (Mn), iron (Fe), cobalt (Co), nickel (Ni), copper (Cu), and zinc (Zn).

The second-row transition metal of the Periodic Table of Elements means an element included in a d-block while being a fifth-row element of the Periodic Table of Elements. Specific examples include yttrium (Y), zirconium (Zr), niobium (Nb), molybdenum (Mo), technetium (Tc), ruthenium (Ru), rhodium (Rh), palladium (Pd), silver (Ag), and cadmium (Cd).

The third-row transition metal of the Periodic Table of Elements means an element included in a d-block and a f-block while being a sixth-row element of the Periodic Table of Elements. Specific examples include lanthanum (La), samarium (Sm), europium (Eu), terbium (Tb), thulium (Tm), ytterbium (Yb), lutetium (Lu), hafnium (Hf), tantalum (Ta), tungsten (W), rhenium (Re), osmium (Os), iridium (Ir), platinum (Pr), gold (Au), and mercury (Hg).

The term “C₁-C₆₀alkyl group” as used herein refers to a linear or branched saturated aliphatic hydrocarbon monovalent group having 1 to 60 carbon atoms, and examples thereof include a methyl group, an ethyl group, a propyl group, an iso-butyl group, a sec-butyl group, a tert-butyl group, a pentyl group, an iso-amyl group, and a hexyl group. The term “C₁-C₆₀alkylene group” as used herein refers to a divalent group having the same structure as the C₁-C₆₀alkyl group.

The term “C₁-C₆₀alkoxy group” as used herein refers to a monovalent group represented by —OA₁₀₁(wherein A₁₀₁is the C₁-C₆₀alkyl group), and examples thereof include a methoxy group, an ethoxy group, and an iso-propyloxy group.

The term “C₂-C₆₀alkenyl group” as used herein refers to a hydrocarbon group having at least one carbon-carbon double bond in the middle or at the terminus of the C₂-C₆₀alkyl group, and examples thereof include an ethenyl group, a propenyl group, and a butenyl group. The term “C₂-C₆₀alkenylene group” as used herein refers to a divalent group having the same structure as the C₂-C₆₀alkenyl group.

The term “C₂-C₆₀alkynyl group” as used herein refers to a hydrocarbon group having at least one carbon-carbon triple bond in the middle or at the terminus of the C₂-C₆₀alkyl group, and examples thereof include an ethynyl group, and a propynyl group. The term “C₂-C₆₀alkynylene group” as used herein refers to a divalent group having the same structure as the C₂-C₆₀alkynyl group.

The term “C₃-C₁₀cycloalkyl group” as used herein refers to a monovalent saturated hydrocarbon monocyclic group having 3 to 10 carbon atoms, and examples thereof include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, and a cycloheptyl group. The term “C₃-C₁₀cycloalkylene group” as used herein refers to a divalent group having the same structure as the C₃-C₁₀cycloalkyl group.

The term “C₁-C₁₀heterocycloalkyl group” as used herein refers to a monovalent saturated monocyclic group having at least one heteroatom selected from N, O, P, Si and S as a ring-forming atom and 1 to 10 carbon atoms, and non-limiting examples thereof include a tetrahydrofuranyl group, and a tetrahydrothiophenyl group. The term “C₁-C₁₀heterocycloalkylene group” as used herein refers to a divalent group having the same structure as the C₁-C₁₀heterocycloalkyl group.

The term “C₃-C₁₀cycloalkenyl group” as used herein refers to a monovalent monocyclic group that has 3 to 10 carbon atoms and at least one carbon-carbon double bond in the ring thereof and no aromaticity, and non-limiting examples thereof include a cyclopentenyl group, a cyclohexenyl group, and a cycloheptenyl group. The term “C₃-C₁₀cycloalkenylene group,” as used herein, refers to a divalent group having the same structure as the C₃-C₁₀cycloalkenyl group.

The term “C₁-C₁₀heterocycloalkenyl group” as used herein refers to a monovalent monocyclic group that has at least one heteroatom selected from N, O, P, Si, and S as a ring-forming atom, 1 to 10 carbon atoms, and at least one carbon-carbon double bond in its ring. Examples of the C₁-C₁₀heterocycloalkenyl group are a 2,3-dihydrofuranyl group and a 2,3-dihydrothiophenyl group. The term “C₁-C₁₀heterocycloalkenylene group,” as used herein, refers to a divalent group having the same structure as the C₁-C₁₀heterocycloalkenyl group.

The term “C₆-C₆₀aryl group” as used herein refers to a monovalent group having a carbocyclic aromatic system having 6 to 60 carbon atoms, and the term “C₆-C₆₀arylene group” as used herein refers to a divalent group having a carbocyclic aromatic system having 6 to 60 carbon atoms. Examples of the C₆-C₆₀aryl group are a phenyl group, a naphthyl group, an anthracenyl group, a phenanthrenyl group, a pyrenyl group, and a chrysenyl group. When the C₆-C₆₀aryl group and the C₆-C₆₀arylene group each include two or more rings, the rings may be fused to each other.

The term “C₁-C₆₀heteroaryl group” as used herein refers to a monovalent group having a cyclic aromatic system that has at least one heteroatom selected from N, O, P, Si, and S as a ring-forming atom, in addition to 1 to 60 carbon atoms. The term “C₁-C₆₀heteroarylene group” as used herein refers to a divalent group having a carbocyclic aromatic system that has at least one heteroatom selected from N, O, P, Si, and S as a ring-forming atom, in addition to 1 to 60 carbon atoms. Examples of the C₁-C₆₀heteroaryl group are a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, and an isoquinolinyl group. When the C₁-C₆₀heteroaryl group and the C₁-C₆₀heteroarylene group each include two or more rings, the rings may be fused to each other.

The term “C₆-C₆₀aryloxy group,” as used herein, indicates —OA₁₀₂(wherein A₁₀₂is the C₆-C₆₀aryl group), and a C₆-C₆₀arylthio group indicates —SA₁₀₃(wherein A₁₀₃is the C₆-C₆₀aryl group).

The term “monovalent non-aromatic condensed polycyclic group” as used herein refers to a monovalent group having two or more rings condensed to each other, only carbon atoms (for example, the number of carbon atoms may be in a range of 8 to 60) as a ring-forming atom, and no aromaticity in its entire molecular structure. Non-limiting examples of the monovalent non-aromatic condensed polycyclic group include a fluorenyl group. The term “divalent non-aromatic condensed polycyclic group” as used herein refers to a divalent group having the same structure as the monovalent non-aromatic condensed polycyclic group.

The term “monovalent non-aromatic condensed heteropolycyclic group” as used herein refers to a monovalent group having two or more rings condensed to each other, a heteroatom selected from N, O, P, Si, and S, other than carbon atoms (for example, the number of carbon atoms may be in a range of 2 to 60), as a ring-forming atom, and no aromaticity in its entire molecular structure. Non-limiting examples of the monovalent non-aromatic condensed heteropolycyclic group include a carbazolyl group. The term “divalent non-aromatic condensed heteropolycyclic group” as used herein refers to a divalent group having the same structure as the monovalent non-aromatic condensed heteropolycyclic group.

The term “C₅-C₃₀carbocyclic group” as used herein refers to a saturated or unsaturated cyclic group having, as a ring-forming atom, 5 to 30 carbon atoms only. The term “C₅-C₃₀carbocyclic group” as used herein refers to a monocyclic group or a polycyclic group, and, according to its chemical structure, a monovalent, divalent, trivalent, tetravalent, pentavalent, or hexavalent group.

The term “C₁-C₃₀heterocyclic group” as used herein refers to a saturated or unsaturated cyclic group having, as a ring-forming atom, at least one heteroatom selected from N, O, Si, P, and S other than 1 to 30 carbon atoms. The term “C₁-C₃₀heterocyclic group” as used herein refers to a monocyclic group or a polycyclic group, and, according to its chemical structure, a monovalent, divalent, trivalent, tetravalent, pentavalent, or hexavalent group.

At least one substituent of the substituted C₅-C₃₀carbocyclic group, the substituted C₁-C₃₀heterocyclic group, the substituted C₁-C₆₀alkyl group, the substituted C₂-C₆₀alkenyl group, the substituted C₂-C₆₀alkynyl group, the substituted C₁-C₆₀alkoxy group, the substituted C₃-C₁₀cycloalkyl group, the substituted C₁-C₁₀heterocycloalkyl group, the substituted C₃-C₁₀cycloalkenyl group, the substituted C₁-C₁₀heterocycloalkenyl group, the substituted C₆-C₆₀aryl group, the substituted C₆-C₆₀aryloxy group, the substituted C₆-C₆₀arylthio group, the substituted C₁-C₆₀heteroaryl group, the substituted monovalent non-aromatic condensed polycyclic group, and the substituted monovalent non-aromatic condensed heteropolycyclic group may be selected from:

deuterium, —F, —Cl, —Br, —I, —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H, —CFH₂, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, and a C₁-C₆₀alkoxy group;

a C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, and a C₁-C₆₀alkoxy group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H, —CFH₂, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₃-C₁₀cycloalkyl group, a C₁-C₁₀heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₁-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₆-C₆₀aryloxy group, a C₆-C₆₀arylthio group, a C₁-C₆₀heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —N(Q₁₁)(Q₁₂), —Si(Q₁₃)(Q₁₄)(Q₁₅), —B(Q₁₆)(Q₁₇), and —P(═O)(Q₁₈)(Q₁₉);

a C₃-C₁₀cycloalkyl group, a C₁-C₁₀heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₁-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₆-C₆₀aryloxy group, a C₆-C₆₀arylthio group, a C₁-C₆₀heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, —CD₃, —CD₂H, —CDH₂, —CF₃, —CF₂H, —CFH₂, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, a C₁-C₆₀alkoxy group, a C₃-C₁₀cycloalkyl group, a C₁-C₁₀heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₁-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₆-C₆₀aryloxy group, a C₆-C₆₀arylthio group, a C₁-C₆₀heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —N(Q₂₁)(Q₂₂), —Si(Q₂₃)(Q₂₄)(Q₂₅), —B(Q₂₆)(Q₂₇), and —P(═O)(Q₂₈)(Q₂₉); and

—N(Q₃₁)(Q₃₂), —Si(Q₃₃)(Q₃₄)(Q₃₅), —B(Q₃₆)(Q₃₇), and —P(═O)(Q₃₈)(Q₃₉), and

Q₁to Q₉, Q₁₁to Q₁₉, Q₂₁to Q₂₉, and Q₃₁to Q₃₉may each independently be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C₁-C₆₀alkyl group, a C₂-C₆₀alkenyl group, a C₂-C₆₀alkynyl group, a C₁-C₆₀alkoxy group, a C₃-C₁₀cycloalkyl group, a C₁-C₁₀heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₁-C₁₀heterocycloalkenyl group, a C₆-C₆₀aryl group, a C₆-C₆₀aryl group substituted with at least one selected from a C₁-C₆₀alkyl group, and a C₆-C₆₀aryl group, a C₆-C₆₀aryloxy group, a C₆-C₆₀arylthio group, a C₁-C₆₀heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group.

The term “room temperature” as used herein refers to a temperature of about 25° C.

The term “biphenyl group” refers to a monovalent group in which two benzene groups are linked via a single bond.

The term “terphenyl group” refers to a monovalent group in which three benzene groups are linked via a single bond.

Hereinafter, a compound and an organic light-emitting device according to embodiments are described in detail with reference to Synthesis Example and Examples. However, the organic light-emitting device is not limited thereto. The wording “‘B’ was used instead of ‘A’” used in describing Synthesis Examples means that a molar equivalent of ‘A’ was identical to a molar equivalent of ‘B’.

EXAMPLES
Example 1

As an anode, a glass substrate, in which an ITO electrode was formed, was cut to a size of 50 mm×50 mm×0.5 mm (mm=millimeter), sonicated with acetone, iso-propyl alcohol, and pure water each for 15 minutes, and then cleaned by exposure to ultraviolet rays for 30 minutes.

F6-TCNNQ was deposited on the anode to form a hole injection layer having a thickness of 100 Angstroms (Å), and Compound HT3 was deposited on the hole injection layer to form a hole transport layer having a thickness of 1,260 Å, thereby forming a hole transport region.

Compound H-H1 and H-E2 (weight ratio of 5:5) (host), Compound 4-333 (sensitizer), and FD17 (dopant) were respectively co-deposited on the hole transport region at 88 percent by weight (wt %), 10 (wt %), and 2 (wt %) to form an emission layer having a thickness of 400 Å.

Compound ET17 and LiQ were co-deposited on the emission layer at a ratio of 5:5 to form an electron transport layer having a thickness of 360 Å, LiQ was deposited on the electron transport layer to form an electron injection layer having a thickness of 5 Å, and Al was deposited on the electron injection layer to a thickness of 800 Å, thereby completing the manufacture of an organic light-emitting device.

embedded image

Examples 2 to 5 and Comparative Examples 1 and 2

Organic light-emitting devices were manufactured in the same manner as in Example 1, except that a sensitizer and a dopant were changed as shown in Table 1 in forming an emission layer.

TABLE 1

Host
Sensitizer
Dopant

Amount

Amount

Amount

Compound
(wt %)
Compound
(wt %)
Compound
(wt %)

Example 1
H-H1:H-E2 (5:5)
88
4-333
10
FD17
2

Example 2
H-H20:H-E16 (5:5)
88
4-333
10
FD17
2

Example 3
H-H61:H-E49 (5:5)
88
4-333
10
FD17
2

Example 4
H-H1:H-E2 (5:5)
88
4-286
10
FD17
2

Example 5
H-H1:H-E2 (5:5)
88
4-98
10
FD17
2

Comparative
H-H1:H-E2 (5:5)
98
—
—
FD17
2

Example 1

Comparative
H-H1:H-E2 (5:5)
88
Ir(ppy)₃
10
FD17
2

Example 2

embedded image

Evaluation Example 1: Evaluation of Device Characteristics

The driving voltage (at 1,500 nit), maximum external quantum efficiency (EQE_max), external quantum efficiency (EQE, at 1500 nit), CIE color coordinates (at 1500 nit), and lifespan (T₉₇) (at 10 milliamperes per square centimeter, mA/cm²) characteristics of the organic light-emitting devices manufactured according to Examples 1 to 5 and Comparative Examples 1 and 2 were measured by using a current-voltage meter (Keithley 2400) and a luminance meter (Minolta Cs-1000A), and results thereof are shown in Table 2 and FIGS. 5 and 6. The lifespan T₉₇(at 10 mA/cm²) in Table 2 is lifespan data obtained by evaluating the amount of time that lapsed when luminance was 97% of initial luminance (100%).

TABLE 2

Driving

voltage
EQE_max
EQE

Lifespan

Host
Sensitizer
Dopant
(V)
(%)
(%)
CIEx
CIEy
(T₉₇) (hr)

Example 1
H-H1:H-E2
4-333
FD17
6.91
6.0
3.7
0.613
0.386
280

(5:5)

Example 2
H-H20:H-E16
4-333
FD17
7.30
5.5
3.2
0.615
0.381
250

(5:5)

Example 3
H-H61:H-E49
4-333
FD17
7.00
5.9
3.2
0.616
0.385
370

(5:5)

Example 4
H-H1:H-E2
4-286
FD17
7.09
4.7
3.0
0.616
0.387
320

(5:5)

Example 5
H-H1:H-E2
4-98
FD17
6.98
5.8
3.7
0.616
0.381
250

(5:5)

Comparative
H-H1:H-E2
—
FD17
7.80
3.7
1.5
0.613
0.386
200

Example 1
(5:5)

Comparative
H-H1:H-E2
Ir(ppy)₃
FD17
7.59
4.4
2.5
0.616
0.382
230

Example 2
(5:5)

Referring to Table 2, it is confirmed that the organic light-emitting devices of Examples 1 to 5 have a low driving voltage, high quantum efficiency, and a long lifespan, as compared with those of the organic light-emitting devices of Comparative Examples 1 and 2.

Specifically, the maximum external quantum efficiency of the organic light-emitting device of Example 1 was improved about 1.6 times, as compared with the organic light-emitting device of Comparative Example 1. The external quantum efficiency (at 1,500 nit) of the organic light-emitting device of Example 1 was improved about 2.5 times, as compared with the organic light-emitting device of Comparative Example 1.

Specifically, the lifespan of the organic light-emitting device of Example 1 was improved about 1.4 times, as the organic light-emitting device of Comparative Example 1.

In addition, it is confirmed that CIE coordinate values of the organic light-emitting devices of Example 1 and Comparative Example 1 are identical to each other. It can be interpreted that only the dopant of the organic light-emitting device of Example 1 substantially emits light.

The organic light-emitting device may have a low driving voltage, high efficiency, and a long lifespan at the same time.

It should be understood that embodiments described herein should be considered in a descriptive sense only and not for purposes of limitation. Descriptions of features or aspects within each embodiment should typically be considered as available for other similar features or aspects in other embodiments.

While one or more embodiments have been described with reference to the figures, it will be understood by those of ordinary skill in the art that various changes in form and details may be made therein without departing from the spirit and scope of the present description as defined by the following claims.

ORGANIC LIGHT-EMITTING DEVICE

Information

Publication Number

Date Filed

Date Published

Inventors

Original Assignees

CPC

International Classifications

Abstract

Description

Claims

Priority Claims (1)